Hypothyroidism (congenital or acquired)

HYPOTHYROIDISM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_CONGEIOD E4_IODGOITRE E4_IODTHYR E4_IODHYPSUB E4_HYTHYSUBS E4_HYTHYPOSTINF E4_ATROTHY E4_MYXOCO E4_HYTHYNAS	75154
6. Filter based on genotype QC (FinnGen only)	67402

Control definitions (FinnGen only)

Control exclude: NEURO_COMORBIDITIES

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	HYPOTHYROIDISM
CONTROL_EXCLUDE	NEURO_COMORBIDITIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_CONGEIOD\|E4_IODGOITRE\|E4_IODTHYR\|E4_IODHYPSUB\|E4_HYTHYSUBS\|E4_HYTHYPOSTINF\|E4_ATROTHY\|E4_MYXOCO\|E4_HYTHYNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypothyroidism (congenital or acquired) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	67402	53780	13622
Unadjusted period prevalence (%)	16.50	19.09	6.25
Median age at first event (years)	52.98	51.13	60.27

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16743: Matched controls
93700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

321.3

6358

22349

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

321.3

1198

1800

N05AF03

ATC

chlorprothixene; systemic

259.3

318.8

408

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

99.6

316.5

280

N06AA12

ATC

doxepin; systemic

15.9

316.3

401

144

B03BA03

ATC

hydroxocobalamin; parenteral

10.5

315.7

488

266

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.1

315.5

4818

15402

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.9

315.2

654

552

L28

ICPC

Limited function/disability (L)

3.2

313.7

1595

2983

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

52.5

312.3

295

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

83.9

312.2

280

F31

ICD-10 Finland

Bipolar affective disorder

153.0

312.1

269

PHD99

NOMESCO Finland

Resection of other vein

2154.5

312.1

382

S18

ICPC

Laceration/cut

2.0

309.8

5820

20028

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

9.5

309.3

508

307

C09CA01

ATC

losartan; oral

2.7

307.7

2141

4811

WZC00

NOMESCO Finland

Treatment plan or consultation

2.2

307.7

5582

17455

C08CA13

ATC

lercanidipine; oral

4.6

307.7

1004

1280

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

11.6

307.7

635

316

T82

ICPC

Obesity

6.0

307.7

869

848

H02AB09

ATC

hydrocortisone; systemic

15.6

307.7

635

236

WF002

NOMESCO Finland

Radical radiotherapy

32.6

307.7

343

A10AB04

ATC

insulin lispro; parenteral

171.0

307.7

618

Z3231

NOMESCO Finland

Registered nurse

3.0

307.7

3431

7508

N03AX09

ATC

lamotrigine; oral

21.6

307.7

1145

317

N05BA01

ATC

diazepam; systemic, rectal

5.8

307.7

1575

1646

I48

ICD-10 Finland

Atrial fibrillation and flutter

95.3

307.7

857

Z01.8

ICD-10 Finland

Other specified special examinations

2.6

307.7

3254

7964

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

16.6

307.7

1167

421

N06AA09

ATC

amitriptyline; systemic

7.9

307.7

873

646

F40.1

ICD-10 Finland

Social phobias

15.5

307.7

500

186

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

7.7

307.7

855

648

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

307.7

4256

11225

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

8939

33012

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.4

307.7

1138

1244

WZC30

NOMESCO Finland

Teaching

3.9

307.7

1938

3031

F90.0

ICD-10 Finland

Disturbance of activity and attention

8.2

307.7

861

618

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

7.5

307.7

694

536

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.6

307.7

2371

2289

N05BA04

ATC

oxazepam; oral

7.4

307.7

4061

3870

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.7

307.7

3487

6208

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1234

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.1

307.7

3837

6386

N05CD07

ATC

temazepam; oral

10.4

307.7

844

474

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

66.5

307.7

315

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

100.9

307.7

1481

C07AA05

ATC

propranolol; systemic

4.5

307.7

3695

5522

C10AA07

ATC

rosuvastatin; oral

2.5

307.7

3743

9777

R53

ICD-10 Finland

Malaise and fatigue

3.0

307.7

4316

9799

115

Kela drug reimbursment

Breast cancer

+∞

307.7

461

N05CF01

ATC

zopiclone; oral

4.8

307.7

3887

5572

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

128.8

307.7

294

C10AX09

ATC

ezetimibe; oral

5.6

307.7

1545

1658

A10AE06

ATC

insulin degludec; parenteral

+∞

307.7

627

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

8.1

307.7

654

469

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

8.2

307.7

618

436

N05AX08

ATC

risperidone; systemic

27.1

307.7

1075

237

N02AX02

ATC

tramadol; systemic, rectal

2.5

307.7

5306

14503

215

Kela drug reimbursment

Diabetes, non-insulin-treated

+∞

307.7

2998

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

127.9

307.7

743

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

14.9

307.7

552

214

UJF32

NOMESCO Finland

Coloscopy

2.9

307.7

2657

5665

N05AH04

ATC

quetiapine; oral

15.9

307.7

3526

1544

C10AA01

ATC

simvastatin; oral

3.7

307.7

2823

4904

SPAT1240

SPAT

Therapeutic discussion

4.4

307.7

2116

3012

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

65.2

307.7

309

H03AA01

ATC

levothyroxine sodium; systemic

12640.9

307.7

16560

666

IGY02

NOMESCO Finland

Psychiatric monitoring contact

27.5

307.7

612

129

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

532.5

307.7

463

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

17.0

307.7

445

150

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

77.0

307.7

924

A10AE05

ATC

insulin detemir; parenteral

741.3

307.7

879

A10AC01

ATC

insulin (human); parenteral

24.5

307.7

1151

282

PJA12

NOMESCO Finland

Sentinel node biopsy

32.6

307.7

443

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

5402

16579

F51.0

ICD-10 Finland

Nonorganic insomnia

2.9

307.7

3063

6686

E66.01

ICD-10 Finland

Obesity due to excess calories

5.0

307.7

2086

2612

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

635.2

307.7

1063

XX3DW

NOMESCO Finland

Time consuming IT work

6.8

307.7

869

744

H04AA01

ATC

glucagon; nasal, parenteral

932.2

307.7

630

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

51.8

307.7

336

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

307.7

3368

8804

A10BJ02

ATC

liraglutide; parenteral

66.1

307.7

336

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

48.8

307.7

499

C03DA01

ATC

spironolactone; oral

7.1

307.7

967

802

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

3118

7140

JN4BD

NOMESCO Finland

Extensive body CT

7.9

307.7

686

507

WX402

NOMESCO Finland

General anaesthesia

2.7

307.7

3296

7758

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

98.1

307.7

444

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

307.7

2570

5572

A04

ICPC

Weakness/tiredness general

2.7

307.7

2525

5706

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

10.9

307.7

930

503

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

9.2

307.7

1468

972

N06BA04

ATC

methylphenidate; oral

8.4

307.7

755

523

H02AB06

ATC

prednisolone; systemic

2.1

307.7

6514

21442

XF402

NOMESCO Finland

ECG with work load test

7.4

307.7

730

571

TPH07

NOMESCO Finland

Cathetrisation of artery

6.9

307.7

925

787

A06AD11

ATC

lactulose; oral

4.5

307.7

1168

1532

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

86.9

307.7

305

F32.9

ICD-10 Finland

Depressive episode, unspecified

20.0

307.7

2738

906

P76

ICPC

Depressive disorder

17.1

307.7

1427

507

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

131.5

307.7

763

C10AA05

ATC

atorvastatin; oral

3.3

307.7

3797

7621

C01DA14

ATC

isosorbide mononitrate; oral

40.0

307.7

560

N05BE01

ATC

buspirone; oral

42.0

307.7

417

N06AX22

ATC

agomelatine; oral

83.8

307.7

480

F33

ICD-10 Finland

Recurrent depressive disorder

31.7

307.7

485

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

17.9

307.7

415

133

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.8

307.7

2258

2450

N05AA02

ATC

levomepromazine; systemic

91.5

307.7

599

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

6.6

307.7

728

644

A10BK03

ATC

empagliflozin; oral

613.9

307.7

933

SPAT1249

SPAT

Treatment-related counselling outside office

2.1

307.7

6195

20784

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

162.7

307.7

425

104

Kela drug reimbursment

Thyroid insufficiency

7212.4

307.7

3163

ZYC01

NOMESCO Finland

Remote contact by phone

5.7

307.7

927

948

P01

ICPC

Feeling anxious/nervous/tense

3.3

307.7

3002

5797

F61.0

ICD-10 Finland

Mixed personality disorders

145.3

307.7

331

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

16.1

307.7

696

251

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

658

N05AB03

ATC

perphenazine; systemic, rectal

77.5

307.7

432

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

307.7

432

N02AA05

ATC

oxycodone; systemic

6.0

307.7

1361

1371

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

3124

6755

N06AG02

ATC

moclobemide; oral

30.6

307.7

422

N06AB10

ATC

escitalopram; oral

15.7

307.7

4016

1842

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

580

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.3

307.7

1789

3290

F29

ICD-10 Finland

Unspecified nonorganic psychosis

428.0

307.7

591

A03FA01

ATC

metoclopramide; systemic, rectal

4.0

307.7

2701

4292

T90

ICPC

Diabetes non-insulin dependent

37.1

307.7

2404

422

P74

ICPC

Anxiety disorder/anxiety state

8.5

307.7

938

650

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

10.3

307.7

737

418

N06AB06

ATC

sertraline; oral

27.2

307.7

2195

516

N02BF02

ATC

pregabalin; oral

5.7

307.7

918

937

N06AX12

ATC

bupropion; oral

31.9

307.7

1820

357

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

9.1

307.7

970

630

N06AX16

ATC

venlafaxine; oral

52.9

307.7

2883

367

A10BH01

ATC

sitagliptin; oral

693.2

307.7

712

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

98.0

307.7

624

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.3

307.7

554

344

B01AB05

ATC

enoxaparin; parenteral

2.9

307.7

3289

7225

A04AA02

ATC

granisetron; systemic, transdermal

94.5

307.7

428

G47.3

ICD-10 Finland

Sleep apnoea

3.6

307.7

3506

6446

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

36.0

307.7

691

112

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.1

307.7

1048

1020

B01AC04

ATC

clopidogrel; oral

16.6

307.7

829

294

SPAT1262

SPAT

Handing over of treatment supplies

9.8

307.7

2034

1306

C09AA05

ATC

ramipril; oral

5.9

307.7

1658

1726

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

307.7

1587

2726

A10AE04

ATC

insulin glargine; parenteral

119.6

307.7

1320

A10AA02, ,

ATC

+∞

307.7

512

N06AB05

ATC

paroxetine; oral

23.0

307.7

896

230

207

Kela drug reimbursment

Chronic arrhythmias

371.2

307.7

638

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

14.2

307.7

512

207

N05BA12

ATC

alprazolam; oral

8.2

307.7

1160

842

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

5.1

307.7

914

1044

E66.8

ICD-10 Finland

Other obesity

7.2

307.7

1114

916

JN4AD

NOMESCO Finland

Body CT examination

9.0

307.7

849

554

D64.9

ICD-10 Finland

Anaemia, unspecified

9.3

307.7

770

482

B01AF02

ATC

apixaban; oral

17.7

307.7

618

203

C09AA02

ATC

enalapril; systemic

4.6

307.7

1313

1714

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

307.7

404

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

671

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

123.8

307.7

389

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

307.7

5702

11032

OAB50, ,

SPAT

10.8

307.7

1055

580

F31.8

ICD-10 Finland

Other bipolar affective disorders

212.2

307.7

443

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

141.1

307.7

1260

R5140

NOMESCO Finland

Monitoring the use of the aid

3.8

307.7

1361

2120

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.7

307.7

1499

2398

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

7.2

307.7

660

529

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.0

307.7

754

625

N06AX11

ATC

mirtazapine; oral

6.6

307.7

5336

6183

E11

ICD-10 Finland

Type 2 diabetes mellitus

29.5

307.7

1324

272

P03

ICPC

Feeling depressed

5.6

307.7

2170

2445

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1166.7

307.7

418

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

95.2

307.7

415

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

34.1

307.7

1866

343

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

307.7

2504

5946

E03

ICD-10 Finland

Other hypothyroidism

282.5

307.7

3731

Z71.8

ICD-10 Finland

Other specified counselling

2.0

307.7

5660

18760

B01AA03

ATC

warfarin; systemic

31.0

307.7

872

166

A10AA01, ,

ATC

+∞

307.7

505

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

6558

22467

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

67.1

307.7

444

Z2445

NOMESCO Finland

Psychologist

11.8

307.7

722

355

N05AN01

ATC

lithium; oral

212.7

307.7

587

AA1AD

NOMESCO Finland

CT of head and brain

4.0

307.7

2820

4503

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

559.0

307.7

579

A28

ICPC

Limited function/disability NOS

4.8

307.7

1049

1300

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.0

307.7

2168

4358

R51.80

ICD-10 Finland

Headache

2.5

307.7

2724

6693

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1478

N02BE01

ATC

paracetamol; systemic, rectal

2.9

307.7

14131

61195

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

83.8

307.7

494

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

382.0

307.7

1716

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

751.5

307.7

1010

E66.00

ICD-10 Finland

Metabolic syndrome

8.7

307.7

772

520

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.7

307.7

1056

1314

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

88.9

307.7

312

AN1

Coronary angiography

134.0

307.7

511

F41.09

ICD-10 Finland

UNS Panic Syndrome

14.8

307.7

490

190

N03AG01

ATC

valproic acid; systemic, rectal

11.1

307.7

1029

549

P29

ICPC

Psychological sympt/compl other

4.5

307.7

1641

2208

N05CF02

ATC

zolpidem; oral

3.7

307.7

2394

4033

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

558

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.3

307.7

4591

13166

F32.1

ICD-10 Finland

Moderate depressive episode

10.3

307.7

1205

703

P99

ICPC

Psychological disorders other

15.4

307.7

631

238

XCK10

NOMESCO Finland

Photography of fundus of eye

5.6

307.7

851

891

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

5994

19036

EP1AE

NOMESCO Finland

Neck ultrasound examination

7.9

307.7

1173

883

XF400

NOMESCO Finland

ECG with 12 standard connections

4.5

307.7

1316

1736

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1194.9

307.7

634

A10AB01

ATC

insulin (human); parenteral

682.0

307.7

701

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

6.2

307.7

733

682

ZY010

NOMESCO Finland

Hospital outpatient

12.5

307.7

1006

477

C08CA01

ATC

amlodipine; oral

3.9

307.7

3193

5399

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.7

307.7

1388

784

T86

ICPC

Hypothyroidism/myxoedema

219.7

307.7

2619

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

96.7

307.7

519

N03AE01

ATC

clonazepam; systemic

8.2

307.7

654

465

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

307.7

1740

3176

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

717

103

Kela drug reimbursment

Diabetes, insulin-treated

10357.6

307.7

3046

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.5

307.7

775

202

IGY99

NOMESCO Finland

Other psychiatric treatment contact

34.0

307.7

433

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

10.5

307.7

2208

1340

F41.1

ICD-10 Finland

Generalized anxiety disorder

11.0

307.7

1183

643

N06AX05

ATC

trazodone; oral

62.6

307.7

372

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

307.7

1247

1806

F34.1

ICD-10 Finland

Dysthymia

56.4

307.7

696

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

82.8

307.7

544

N06AB03

ATC

fluoxetine; oral

21.8

307.7

1817

521

I10

ICD-10 Finland

Essential (primary) hypertension

3.3

307.7

5689

12765

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

84.7

307.7

485

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

9.1

307.7

1383

920

I25.1

ICD-10 Finland

Atherosclerotic heart disease

95.1

307.7

1097

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

67.6

307.7

2170

206

N06AX26

ATC

vortioxetine; oral

42.1

307.7

1590

233

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

307.7

3272

8123

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.5

307.7

2109

1570

XF404

NOMESCO Finland

Ambulatory ECG

10.1

307.7

621

357

E10

ICD-10 Finland

Type 1 diabetes mellitus

848.3

307.7

438

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

12.8

307.7

787

360

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

307.7

2420

5455

N05AH03

ATC

olanzapine; systemic

134.3

307.7

1183

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

554

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.9

307.7

756

559

H03BB01

ATC

carbimazole; oral

16.4

307.7

1458

542

C07AB02

ATC

metoprolol; systemic

5.7

307.7

1465

1540

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

128.2

307.7

446

I50.9

ICD-10 Finland

Heart failure, unspecified

174.7

307.7

485

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

550.1

307.7

8540

177

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

15.6

307.7

864

326

R06.0

ICD-10 Finland

Dyspnoea

3.4

307.7

3346

6461

E03.89

ICD-10 Finland

Other specified hypothyroidism

295.6

307.7

2123

N05AX12

ATC

aripiprazole; systemic

464.6

307.7

1014

N03AX16

ATC

[U] pregabalin

4.1

307.7

2809

4393

N03AX12

ATC

[U] gabapentin; oral

4.1

307.7

1932

2919

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

10.6

307.7

584

317

Z2446

NOMESCO Finland

Social worker

7.4

307.7

902

712

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.1

307.7

1366

1987

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

55.0

307.7

375

N06AB04

ATC

citalopram; systemic

19.1

307.7

3066

1086

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

27.0

307.7

364

F32

ICD-10 Finland

Depressive episode

11.6

307.7

1008

513

P06

ICPC

Sleep disturbance

3.2

307.7

2175

4216

A11CC03

ATC

alfacalcidol; systemic

54.2

307.7

360

205

Kela drug reimbursment

Chronic hypertension

+∞

307.7

1454

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

307.7

716

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

68.6

307.7

430

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

633.4

307.7

653

BAA60

NOMESCO Finland

Total thyroidectomy

753.0

307.7

1360

L03AA13

ATC

pegfilgrastim; parenteral

75.1

307.7

316

C07AB07

ATC

bisoprolol; oral

6.8

307.7

4921

5377

A10BA02

ATC

metformin; oral

27.6

307.7

3089

763

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

8.2

307.7

971

702

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

7.7

307.7

2385

1970

N06AX21

ATC

duloxetine; oral

18.7

307.7

2013

678

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

1090.8

307.7

950

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

48.8

307.7

734

A10BK01

ATC

dapagliflozin; oral

254.7

307.7

698

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

21.3

307.7

1030

287

N06AX03

ATC

mianserin; oral

31.4

307.7

502

C03CA01

ATC

furosemide; systemic

13.3

307.7

1953

920

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

29.5

307.7

605

119

A02BC02

ATC

pantoprazole; systemic

2.8

307.7

9772

31082

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.2

307.7

795

749

N05BA06

ATC

lorazepam; systemic, sublingual

29.8

307.7

551

107

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

80.9

307.7

326

H02AB02

ATC

dexamethasone; systemic

16.8

307.7

880

309

A10AB05

ATC

insulin aspart; parenteral

205.3

307.7

1256

T89

ICPC

Diabetes insulin dependent

349.0

307.7

886

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.9

306.0

570

417

R02

ICPC

Shortness of breath/dyspnoea

3.1

305.9

1622

3113

R4110

NOMESCO Finland

Physiotherapy

2.4

305.2

2958

7826

C09CA06

ATC

candesartan; oral

2.4

305.2

2953

7807

J01DB01

ATC

cefalexin; oral

2.1

303.1

13338

60890

A04AA55

ATC

palonosetron, combinations; systemic

115.9

302.7

265

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

301.6

6038

21194

JN3AD

NOMESCO Finland

Abdominal CT examination

3.4

301.4

1412

2500

R42

ICD-10 Finland

Dizziness and giddiness

2.5

300.8

2572

6413

M04AA01

ATC

allopurinol; systemic

5.1

300.8

813

920

F99

ICD-10 Finland

Mental disorder, not otherwise specified

31.1

300.3

311

SPAT1310

SPAT

Counselling related to known health issue

2.1

300.3

4506

14264

SPAT1097

SPAT

Recording of ECG

3.6

299.9

1252

2045

M79.7

ICD-10 Finland

Fibromyalgia

8.7

298.0

519

344

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

296.8

816

939

A02BC01

ATC

omeprazole; systemic

2.2

296.2

3249

9066

I47.1

ICD-10 Finland

Supraventricular tachycardia

20.5

294.4

341

E06.3

ICD-10 Finland

Autoimmune thyroiditis

25.3

294.0

320

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

293.7

1168

1840

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

21.8

293.3

333

R4190

NOMESCO Finland

Nutritional therapy

6.9

292.8

603

504

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

291.4

354

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

5.0

289.8

814

956

TFP20

NOMESCO Finland

Cardiodefibrillation

684.0

288.9

359

SPAT1263

SPAT

Sampling

1.9

287.8

6238

22399

I20.99

ICD-10 Finland

Angina pectoris, unspecified

73.9

286.5

260

C03AA03

ATC

hydrochlorothiazide; oral

9.1

286.4

484

306

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

60.0

284.3

264

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1032.2

284.3

351

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

284.0

345

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.6

282.1

1165

1886

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

280.7

11900

52708

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

280.2

2488

6300

F41.00

ICD-10 Finland

Moderate panic disorder

69.3

280.2

256

N07BB01

ATC

disulfiram; oral

7.9

279.8

519

377

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

34.6

276.6

280

F39

ICD-10 Finland

Unspecified mood [affective] disorder

20.8

276.1

318

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

11.7

275.9

402

196

E66.9

ICD-10 Finland

Obesity, unspecified

5.8

275.2

659

657

SPAT1260

SPAT

Consultation of another employee

2.5

274.1

2272

5563

G44.2

ICD-10 Finland

Tension-type headache

2.5

272.7

2206

5336

WX892

NOMESCO Finland

Monitored bed care

5.8

272.1

648

642

L17

ICPC

Foot/toe symptom/complaint

2.0

271.9

4048

12702

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

270.8

2604

6832

WX872

NOMESCO Finland

Intensive care

14.5

270.6

357

141

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

270.1

6588

24441

N02BF01

ATC

gabapentin; oral

3.4

269.4

1234

2147

P01AB01

ATC

metronidazole; oral, rectal

1.9

269.3

5656

19995

ZX120

NOMESCO Finland

Intravenous

4.2

268.7

907

1254

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

385.6

268.0

338

M54.5

ICD-10 Finland

Low back pain

1.9

267.8

5630

19901

J01AA02

ATC

doxycycline; systemic

1.8

266.9

11133

48608

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

266.8

4277

13774

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

265.8

323

Z3226

NOMESCO Finland

Physiotherapist

2.6

264.9

1959

4525

101

Kela drug reimbursment

Anterior pituitary hypofunction

21.9

264.5

300

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

35.9

263.6

265

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

262.5

4974

16962

A02BC03

ATC

lansoprazole; oral

2.2

262.3

2957

8303

SPAT1301

SPAT

No procedures

2.0

262.0

4050

12860

ZXE00

NOMESCO Finland

One hour or less

1.9

261.7

5152

17792

A04AA01

ATC

ondansetron; systemic, rectal

4.7

260.5

772

952

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.2

260.4

1321

2457

R11

ICD-10 Finland

Nausea and vomiting

3.3

259.0

1239

2218

201

Kela drug reimbursment

Chronic cardiac insufficiency

49.9

258.6

246

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1769.8

257.6

316

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

5.8

256.1

609

602

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

254.6

4309

14109

K78

ICPC

Atrial fibrillation/flutter

44.9

253.5

245

ZY000

NOMESCO Finland

Hospital inpatient

105.4

253.1

223

Z51.5

ICD-10 Finland

Palliative care

14.5

252.8

333

131

CL2S4, ,

SPAT

85.5

252.3

226

R50.9

ICD-10 Finland

Fever, unspecified

2.5

251.1

2091

5117

N06AB08

ATC

fluvoxamine; oral

31.7

249.4

257

C08CA02

ATC

felodipine; oral

7.3

248.7

491

388

I49.3

ICD-10 Finland

Ventricular premature depolarization

5.6

248.5

617

639

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.7

247.8

524

452

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

247.1

2499

6684

N05AH02

ATC

clozapine; systemic

585.0

246.9

308

C02AC05

ATC

moxonidine; oral

21.8

246.7

280

J02AC01

ATC

fluconazole; systemic

1.8

245.8

6108

22614

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

224.5

245.1

316

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

353.0

245.0

310

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

244.7

4359

14495

A01

ICPC

Pain general/multiple sites

3.3

244.4

1186

2141

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

26.2

243.9

263

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.4

243.1

785

1044

E23.00

ICD-10 Finland

Panhypopituitarism

120.2

242.6

212

IGY02, ,

SPAT

21.4

240.9

275

E66

ICD-10 Finland

Obesity

3.6

238.9

1012

1664

M03BX02

ATC

tizanidine; oral

1.7

238.1

9584

40711

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1630.7

237.8

292

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

237.7

289

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

847.5

237.3

294

L03

ICPC

Low back symptom/complaint

1.9

237.3

4421

14898

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

236.9

288

SPAT1307

SPAT

Psychosocial counselling and guidance

3.0

236.3

1283

2485

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

234.8

1198

2232

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.1

234.4

805

1127

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

234.4

1556

3384

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

11.9

234.2

339

163

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

33.8

234.0

238

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.5

233.0

1027

1736

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

115.6

232.9

204

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

115.6

232.9

204

F60.9

ICD-10 Finland

Personality disorder, unspecified

52.0

232.6

220

N05AD01

ATC

haloperidol; systemic

21.4

231.4

264

L03AA02

ATC

filgrastim; parenteral

83.8

230.7

207

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

13.1

229.6

316

137

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

9.7

229.5

371

218

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

228.6

278

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

23.6

228.0

253

R60.0

ICD-10 Finland

Localized oedema

3.1

227.5

1177

2211

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

207.7

226.4

293

SPAT1153

SPAT

Removal of sutures

2.0

226.3

3313

10240

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

32.1

225.7

232

SPAT1234

SPAT

Support of social functional capacity

8.5

225.3

398

269

SPAT1243

SPAT

Psychiatric/psychological examination

6.5

224.5

487

433

J01MA12

ATC

levofloxacin; systemic

2.5

223.3

1746

4130

IHZ05, ,

SPAT

3.5

220.5

934

1534

XA800

NOMESCO Finland

Neuropsychological investigation

5.8

219.7

522

515

HA1AA

NOMESCO Finland

X-ray mammography

5.0

218.9

603

693

M25.5

ICD-10 Finland

Pain in joint

1.8

217.5

5061

18210

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1486.3

217.2

267

C07AG02

ATC

carvedilol; oral

13.9

217.1

291

119

WF003

NOMESCO Finland

Adjuvant radiotherapy

70.1

217.0

198

OAB93, ,

SPAT

2.8

216.5

1337

2789

A10BH05

ATC

linagliptin; oral

1480.5

216.4

266

H3600, E103,

ICD-10 Finland

+∞

215.4

262

A10BB12

ATC

glimepiride; oral

761.9

215.1

267

N04AA02

ATC

biperiden; systemic

36.9

215.1

215

Z2221

NOMESCO Finland

Medical doctor

2.0

213.6

3396

10785

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

13.1

213.2

294

128

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

211.9

2585

7436

R00.2

ICD-10 Finland

Palpitations

3.0

210.1

1165

2281

WX002

NOMESCO Finland

Sedation and analgesia

2.4

209.2

1773

4354

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

209.2

8767

37082

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

209.0

3132

9730

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

207.2

252

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

206.4

3288

10434

PHD76

NOMESCO Finland

Resection of long saphenous vein

727.3

206.1

256

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

6.0

206.0

474

451

F32.8

ICD-10 Finland

Other depressive episodes

17.0

205.6

254

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

205.1

1863

4723

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.7

204.9

602

735

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

86.3

204.5

183

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

11.3

203.4

301

151

J01FF01

ATC

clindamycin; systemic

1.9

203.3

3409

11003

B81

ICPC

Anaemia vit B12/folate deficiency

11.2

203.0

302

153

TPX10

NOMESCO Finland

Implantation of vascular injection port

15.3

202.8

261

SPAT1252

SPAT

Overall medication plan or its review

5.6

202.6

503

520

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

69.8

202.6

185

N04BC05

ATC

pramipexole; oral

4.1

202.1

703

993

L02BA01

ATC

tamoxifen; oral

22.8

200.9

225

ZXA10

NOMESCO Finland

Bilateral

2.3

199.6

1860

4767

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

199.6

1483

3411

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

199.0

1586

3777

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

40.9

198.7

195

B01AB10

ATC

tinzaparin; parenteral

3.0

198.7

1077

2078

N06AA06

ATC

trimipramine; systemic

17.9

198.3

240

SPAT1216

SPAT

Assessment of functional ability

2.9

198.1

1191

2443

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

15.2

197.9

255

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

196.4

239

F20.9

ICD-10 Finland

Schizophrenia, unspecified

692.5

196.2

244

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

196.0

4896

17878

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.5

195.8

842

1396

K80

ICPC

Cardiac arrhythmia NOS

3.7

195.8

791

1254

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

195.3

2488

7259

P72

ICPC

Schizophrenia

282.2

195.1

249

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.1

194.6

666

928

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

20.8

194.6

224

Angiography of the heart and coronary arteries

76.6

194.5

176

J01MA02

ATC

ciprofloxacin; systemic

1.8

194.4

4308

15176

C61

ICD-10 Finland

Malignant neoplasm of prostate

14.4

194.0

256

101

I20.09

ICD-10 Finland

Unstable angina

178.0

193.1

252

HAC20

NOMESCO Finland

Total mastectomy

37.3

191.5

191

TK800

NOMESCO Finland

Hemodialysis

37.3

191.5

191

A02BA02

ATC

ranitidine; systemic

2.4

191.4

1592

3867

E0000UV, ,

ATC

1.7

191.0

6273

24674

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

190.8

3661

12321

SPAT1229

SPAT

Assessment of need for aid

4.9

190.7

538

632

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

190.2

2323

6662

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

11.3

190.2

282

142

ZXD05

NOMESCO Finland

Urgent procedure

1.8

190.2

3941

13586

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.0

189.4

348

249

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

189.0

230

R4110, ,

SPAT

2.5

189.0

1463

3431

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

80.1

188.7

170

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

188.2

229

R06AE07

ATC

cetirizine; oral

1.7

187.1

6920

28034

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

11.2

186.4

277

140

Z01.7

ICD-10 Finland

Laboratory examination

2.0

186.4

2479

7342

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

10.5

185.7

287

156

M01AE02

ATC

naproxen; oral, rectal

1.6

185.7

8870

38313

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

185.4

1724

4407

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

185.4

1238

2689

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.8

184.2

701

1062

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

57.2

184.2

172

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

6.8

183.8

382

322

S97

ICPC

Chronic ulcer skin

6.0

183.5

421

399

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

183.3

223

I35.0

ICD-10 Finland

Aortic (valve) stenosis

34.9

183.1

185

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.2

182.8

906

1651

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.4

182.4

396

352

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

26.4

182.2

196

K59.09

ICD-10 Finland

Constipation, unspecified

4.2

182.2

609

832

C09BA02

ATC

enalapril and diuretics; systemic

7.1

182.0

365

294

F33.8

ICD-10 Finland

Other recurrent depressive disorders

77.2

181.4

164

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

181.0

8313

35464

F60.5

ICD-10 Finland

Anankastic personality disorder

21.2

180.1

206

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

179.9

1113

2317

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

179.1

218

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

166.7

178.5

234

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

178.3

217

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

178.3

4583

16785

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

52.8

178.0

168

TFP34

NOMESCO Finland

Electrophysiological investigation

258.0

178.0

228

J01FA06

ATC

roxithromycin; oral

1.7

177.8

5018

18859

SPAT1254

SPAT

Administration of medicine

2.3

177.6

1663

4260

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

177.2

4471

16283

H36.00

ICD-10 Finland

Diabetic background retinopathy

421.1

177.2

223

M79.1

ICD-10 Finland

Myalgia

2.0

176.5

2321

6833

R01AD09

ATC

mometasone; nasal

1.6

175.6

7355

30588

IBA03

NOMESCO Finland

Psychotherapy evaluation

45.5

175.3

169

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

175.1

4021

14242

A10AD01

ATC

insulin (human); parenteral

617.7

174.9

218

A46

ICD-10 Finland

Erysipelas

2.6

174.5

1272

2890

A29

ICPC

General symptom/complaint other

2.4

174.2

1481

3628

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

29.4

173.7

182

N06AX18

ATC

reboxetine; oral

60.3

172.4

160

N03AX11

ATC

topiramate; oral

5.7

172.3

415

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

171.7

209

C01AA05

ATC

digoxin; systemic

26.2

171.6

185

I25

ICD-10 Finland

Chronic ischaemic heart disease

37.2

171.4

171

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

12.6

171.3

240

108

SPAT1312

SPAT

General health counselling

1.7

171.2

4853

18222

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.0

168.6

926

1797

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

13.6

168.6

228

XW000

NOMESCO Finland

Bone marrow biopsy

9.9

167.9

268

154

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

167.8

7370

30892

I25.2

ICD-10 Finland

Old myocardial infarction

591.9

167.5

209

B01AF01

ATC

rivaroxaban; oral

3.4

167.2

760

1307

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

13.3

167.0

228

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

166.8

203

XF600

NOMESCO Finland

Bloodpressure measurement

3.9

166.1

609

896

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

165.9

202

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

165.6

815

1477

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

28.9

165.4

174

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

165.3

12324

58619

ZXA00

NOMESCO Finland

Right side

2.0

164.1

2252

6723

WZC00, ,

SPAT

2.0

163.7

2180

6435

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

163.5

199

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

26.2

163.3

176

UKC02

NOMESCO Finland

Cystoscopy

2.7

162.9

1086

2352

A10BJ05

ATC

dulaglutide; parenteral

+∞

162.7

198

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

162.7

198

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

+∞

162.7

198

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

198.4

162.7

211

A99

ICPC

Disease/condition unspecnature/site

2.5

162.5

1230

2845

I50.0

ICD-10 Finland

Congestive heart failure

236.1

162.5

209

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

42.5

162.1

158

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.2

161.6

548

757

SPAT1139

SPAT

Nutrition survey

5.6

161.5

398

408

N05BA02

ATC

chlordiazepoxide; systemic

16.8

160.7

199

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

18.0

160.6

194

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.6

160.3

668

1081

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

160.2

195

HAB40

NOMESCO Finland

Wedge excision of mammary gland

13.1

160.1

220

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

288.3

160.0

204

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

10.9

160.0

241

125

WX290

NOMESCO Finland

Other blockage of nerve

1.6

158.7

8600

37689

A12AA04

ATC

calcium carbonate; oral

45.5

158.7

153

B02AA02

ATC

tranexamic acid; systemic

2.0

158.5

2055

6001

K02.1

ICD-10 Finland

Caries of dentine

1.6

158.4

10188

46452

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.2

158.2

210

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

13.8

157.9

212

R55

ICD-10 Finland

Syncope and collapse

2.8

157.8

995

2090

D07AC01

ATC

betamethasone; topical

1.7

157.4

4814

18360

127

Kela drug reimbursment

Transplant complication

36.9

157.2

157

J01DA01

ATC

[U] cefalexin

1.6

157.1

8704

38303

A08

ICPC

Swelling

5.0

156.9

430

491

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

17.1

156.8

193

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

156.7

2601

8287

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

156.1

190

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.6

156.1

643

1032

N06BA12

ATC

lisdexamfetamine; oral

13.0

155.5

215

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

23.7

155.4

172

I50.1

ICD-10 Finland

Left ventricular failure

1049.9

154.7

191

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

154.4

188

GD1AD

NOMESCO Finland

Thorax CT examination

4.4

154.4

490

640

F50.9

ICD-10 Finland

Eating disorder, unspecified

11.1

154.3

230

117

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

153.7

3388

11792

E87.6

ICD-10 Finland

Hypokalaemia

9.2

153.6

256

158

WX780

NOMESCO Finland

Remote monitoring CPAP

3.8

153.4

587

892

N06AA04

ATC

clomipramine; systemic

25.9

152.7

165

F10.20

ICD-10 Finland

Alcohol dependence currently independent

12.7

152.6

213

R52.2

ICD-10 Finland

Other chronic pain

4.9

152.6

430

504

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

152.6

1768

4939

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

29.9

152.4

159

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.8

152.3

586

894

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

152.2

1181

2763

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

151.9

185

C01BC04

ATC

flecainide; systemic

29.0

151.2

159

D01

ICPC

Abdominal pain/cramps general

2.0

151.2

1949

5672

R05

ICPC

Cough

1.7

151.2

3448

12112

H3601, E103,

ICD-10 Finland

+∞

151.1

184

L01

ICPC

Neck symptom/complaint

1.9

150.2

2410

7582

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.9

150.0

256

164

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.1

149.7

521

735

R13

ICD-10 Finland

Dysphagia

3.2

149.2

722

1293

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.7

149.1

227

120

H3603, E103,

ICD-10 Finland

+∞

148.7

181

D11

ICPC

Diarrhoea

2.0

148.2

1962

5764

C09DA01

ATC

losartan and diuretics; oral

3.3

147.8

701

1239

M01AB05

ATC

diclofenac; systemic, rectal

1.5

147.7

9349

42141

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

31.8

147.6

152

J01EA01

ATC

trimethoprim; systemic

1.8

147.6

3003

10190

ZX114

NOMESCO Finland

Intramuscular

8.8

147.3

252

162

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

8.0

147.1

269

191

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

5.8

146.7

346

338

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

146.1

777

1477

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.2

146.0

698

1240

B01AC24

ATC

ticagrelor; oral

212.0

145.4

188

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

145.1

963

2078

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.7

145.0

937

1993

F41.3

ICD-10 Finland

Other mixed anxiety disorders

7.3

144.9

283

220

J01CA08

ATC

pivmecillinam; oral

1.6

144.8

5779

23430

R52.9

ICD-10 Finland

Pain, unspecified

2.3

144.8

1347

3428

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

10.2

144.7

226

125

H36.01

ICD-10 Finland

Diabetic maculopathy

344.6

144.5

183

R03DC03

ATC

montelukast; oral

1.9

144.4

2414

7691

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

143.8

4934

19282

A11

ICPC

Chest pain NOS

3.1

143.2

755

1427

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

177.3

143.2

187

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.7

143.0

568

887

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.6

142.3

431

540

R01AD12

ATC

fluticasone furoate; nasal

1.6

142.2

5583

22524

N05AF01

ATC

flupentixol; systemic

36.4

141.8

142

IGV01

NOMESCO Finland

Psychiatric network contact

133.0

141.3

188

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

255.3

141.3

181

3051, ,

Kela drug reimbursment

23.8

141.2

156

XKD00

NOMESCO Finland

Uroflowmetry

2.7

141.1

921

1969

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

140.8

1716

4881

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

205.1

140.6

182

EBA15

NOMESCO Finland

Extraction of multiple teeth

5.6

140.5

343

348

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.6

140.3

421

523

C50

ICD-10 Finland

Malignant neoplasm of breast

61.1

140.3

130

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

8.3

139.9

249

170

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

139.7

1171

2840

WF049

NOMESCO Finland

Radiotherapy of metastasis

333.2

139.6

177

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.3

139.5

661

1167

JHB00

NOMESCO Finland

Hemorrhoidectomy

8.9

139.4

237

151

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.6

139.1

1025

2334

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.2

139.1

365

399

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

9.3

138.8

229

139

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

331.2

138.8

176

R60.9

ICD-10 Finland

Oedema, unspecified

3.7

138.7

539

828

SFA10

NOMESCO Finland

One-surface restoration

1.5

138.4

9080

40984

R03BB04

ATC

tiotropium bromide; inhalant

3.3

138.3

654

1153

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

+∞

138.0

168

K04

ICPC

Palpitations/awareness of heart

3.4

137.5

622

1065

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

137.2

812

1643

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

137.1

167

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

137.1

167

T85

ICPC

Hyperthyroidism/thyrotoxicosis

16.2

137.0

172

H02AB04

ATC

methylprednisolone; systemic

2.1

136.8

1562

4329

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

135.5

165

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

9.7

135.5

218

127

N03AF01

ATC

carbamazepine; oral, rectal

4.1

135.4

462

641

RD210, ,

NOMESCO Finland

7.5

135.3

259

196

SFA30

NOMESCO Finland

Three-surface restoration

1.6

135.1

5892

24282

OAB42, ,

SPAT

2.0

134.9

1850

5495

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

143.9

134.6

178

C10AA04

ATC

fluvastatin; oral

4.7

134.6

389

467

N17

ICPC

Vertigo/dizziness

2.3

134.4

1317

3424

SPAT1281

SPAT

Other administrative function

2.6

134.4

946

2104

M01AH05

ATC

etoricoxib; oral

1.5

134.2

9168

41619

IHZ04, ,

SPAT

6.6

134.0

285

247

CK2S4, ,

SPAT

31.1

133.5

138

K59.1

ICD-10 Finland

Functional diarrhoea

3.2

133.1

659

1197

R07.3

ICD-10 Finland

Other chest pain

2.4

133.0

1076

2564

E23.05

ICD-10 Finland

Lack of TSH

142.3

132.9

176

L02BG04

ATC

letrozole; oral

2.8

132.5

810

1669

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.5

132.4

993

2280

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.0

132.2

705

1341

WX723

NOMESCO Finland

CPAP therapy

3.5

132.1

557

908

N06AA10

ATC

nortriptyline; systemic

8.7

131.9

228

149

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

192.5

131.7

171

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

131.5

1046

2472

160

Kela drug reimbursment

exenatide

+∞

131.4

160

N05AL01

ATC

sulpiride; systemic

42.5

131.3

128

SFA20

NOMESCO Finland

Two-surface restoration

1.5

130.7

9643

44374

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

130.7

1226

3126

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

130.5

159

C07AB03

ATC

atenolol; systemic

7.4

130.0

252

194

P15

ICPC

Chronic alcohol abuse

5.5

129.9

323

334

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

129.1

580

988

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

129.0

2303

7474

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

128.9

653

1203

SPAT1255

SPAT

Intravenous administration of medicine

3.3

128.8

590

1018

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

916.0

128.4

159

M70.6

ICD-10 Finland

Trochanteric bursitis

2.3

128.3

1174

2960

C01BD01

ATC

amiodarone; systemic

454.5

128.2

161

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.9

128.1

218

139

I47.2

ICD-10 Finland

Ventricular tachycardia

52.5

128.1

121

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

128.1

156

J01FA10

ATC

azithromycin; systemic

1.5

127.9

9548

43951

N18.8

ICD-10 Finland

Other chronic renal failure

20.7

127.7

147

SPAT1377

SPAT

Polysomnography

4.5

127.6

389

490

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

127.5

996

2333

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

304.6

127.4

162

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

9.8

127.3

204

118

K85

ICPC

Elevated blood pressure

2.3

127.1

1198

3060

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

126.5

1629

4721

F93.89

ICD-10 Finland

Other childhood emotional disorders

302.7

126.5

161

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

28.0

126.5

134

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

126.4

3729

13950

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

126.4

154

K30

ICD-10 Finland

Functional dyspepsia

2.1

126.4

1492

4183

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

35.8

126.4

127

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

6.9

126.2

257

211

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

125.8

1139

2858

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

125.6

1313

3505

OAA65, ,

SPAT

1.6

125.3

3900

14784

WX722

NOMESCO Finland

PEEP

4.7

125.3

370

453

AA400

NOMESCO Finland

Electroconvulsive therapy

890.7

125.1

155

A41.9

ICD-10 Finland

Sepsis, unspecified

6.6

125.0

263

225

ZXA05

NOMESCO Finland

Left side

1.9

125.0

1993

6229

ICB06, ,

NOMESCO Finland

134.0

124.9

166

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

124.6

3075

10969

C09CA03

ATC

valsartan; oral

3.2

124.5

608

1094

M48.0

ICD-10 Finland

Spinal stenosis

2.8

124.4

747

1523

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

884.4

124.3

154

N05AE04

ATC

ziprasidone; systemic

+∞

124.0

151

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

223.8

123.4

159

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

295.0

123.3

157

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

123.1

150

C50.99

ICD-10 Finland

Breast, unspecified

38.2

122.9

122

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.1

122.7

331

372

J01FA09

ATC

clarithromycin; systemic

1.6

122.6

4394

17221

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

122.4

506

813

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

121.9

2905

10255

F60.8

ICD-10 Finland

Other specific personality disorders

44.3

121.9

118

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.6

121.7

230

171

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.5

121.7

199

119

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.1

121.6

637

1198

M01AC06

ATC

meloxicam; systemic, rectal

1.6

121.6

4006

15382

K59.0

ICD-10 Finland

Constipation

3.2

121.3

584

1041

SPAT1283

SPAT

Restricted health certificate

1.6

121.2

3592

13432

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.2

121.2

583

1039

N01

ICPC

Headache

1.8

121.1

2116

6809

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

7.7

121.1

227

167

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

120.9

1241

3286

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

120.7

147

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

41.6

120.6

118

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

120.2

1112

2815

C10AA03

ATC

pravastatin; oral

4.4

120.2

375

482

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

129.1

120.1

160

A10BG03

ATC

pioglitazone; oral

287.4

120.0

153

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

6.5

119.8

257

225

N03AF02

ATC

oxcarbazepine; oral

4.1

119.5

406

561

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.3

119.4

384

507

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.0

119.2

631

1194

R96

ICPC

Asthma

2.3

119.0

1118

2850

Z49.1

ICD-10 Finland

Extracorporeal dialysis

56.8

118.7

111

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

118.7

829

1834

L04AA06

ATC

mycophenolic acid; systemic

9.5

118.7

194

116

TAB00

NOMESCO Finland

Lumbar puncture

3.2

118.3

584

1058

T99

ICPC

Endocr/metab/nutrit disease other

7.9

118.2

217

155

WX882

NOMESCO Finland

High dependency care

6.5

118.2

253

221

I48.1

ICD-10 Finland

Persistent atrial fibrillation

112.3

118.0

159

SPAT1104

SPAT

Monitoring of emergency patient

3.1

117.9

601

1111

OAB72

NOMESCO Finland

Weight control and weight loss guidance

10.0

117.7

186

105

N19

ICD-10 Finland

Unspecified kidney failure

9.3

117.5

194

118

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.2

117.4

1219

3242

F32.0

ICD-10 Finland

Mild depressive episode

4.3

117.3

383

512

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.1

116.9

606

1132

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.5

116.7

354

444

S29

ICPC

Skin symptom/complaint other

1.8

116.6

2410

8158

R01AD08

ATC

fluticasone; nasal

1.6

116.6

4217

16526

H02AB07

ATC

prednisone; oral

2.1

116.2

1321

3645

Z08

ICPC

Social welfare problem

15.5

115.8

148

D06

ICPC

Abdominal pain localized other

2.1

115.7

1294

3547

R03BA02

ATC

budesonide; inhalant

1.8

115.6

2341

7875

L01BC06

ATC

capecitabine; oral

98.5

115.2

157

IEY01

NOMESCO Finland

Psychoeducation, individual

109.4

114.8

155

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

114.0

1112

2879

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.7

114.0

444

683

LCA06

NOMESCO Finland

Biopsy of endometrium

2.1

113.3

1344

3769

R5110, ,

SPAT

3.0

113.2

616

1185

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

113.1

1969

6320

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

796.5

112.8

140

L15

ICPC

Knee symptom/complaint

1.7

112.8

3075

11229

JN4CD

NOMESCO Finland

Very extensive body CT

9.9

112.7

179

102

G04BD12

ATC

mirabegron; oral

2.6

112.7

768

1677

M02AA07

ATC

piroxicam; topical

1.6

112.5

3512

13268

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

112.5

644

1277

J01CA04

ATC

amoxicillin; systemic

1.6

112.3

13429

67269

R74

ICPC

Upper respiratory infection acute

1.5

112.3

6247

26823

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

39.1

112.3

111

IER01

NOMESCO Finland

Psychoeducation, group

166.7

112.2

147

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

30.0

112.2

117

M01AH01

ATC

celecoxib; oral

1.9

112.2

1647

4994

R4120

NOMESCO Finland

Occupational therapy

2.9

112.0

621

1208

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

111.9

9831

46152

A04AD12

ATC

aprepitant; systemic

139.3

111.7

148

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

111.6

136

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

13.5

111.6

151

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

111.4

1214

3291

ZYY01

NOMESCO Finland

Contact between professionals

46.4

111.3

107

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

784.0

111.2

138

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

6.9

111.2

227

187

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

+∞

110.8

135

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

110.8

135

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.7

110.8

161

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

110.2

749

1633

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

8.1

110.1

199

139

L02

ICPC

Back symptom/complaint

2.0

110.0

1578

4744

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.3

110.0

518

910

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

20.5

109.9

127

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

109.9

636

1269

R06.5

ICD-10 Finland

Mouth breathing

2.1

109.8

1192

3226

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

109.6

3181

11793

R01AD58

ATC

fluticasone, combinations; nasal

1.5

109.5

4454

17879

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

109.5

1466

4300

TKC20

NOMESCO Finland

Catheterisation of bladder

3.7

109.2

419

637

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

109.2

133

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

13.6

108.9

147

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

765.4

108.7

135

R03BA05

ATC

fluticasone; inhalant

1.7

108.6

2476

8607

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

10.5

108.6

167

SPAT1058

SPAT

PEF monitoring instruction

2.5

108.4

822

1894

N30.0

ICD-10 Finland

Acute cystitis

1.8

108.2

2155

7203

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

7.3

108.1

211

164

EBA00

NOMESCO Finland

Extraction of tooth

1.5

107.7

5543

23372

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

107.7

5679

24065

K86

ICPC

Hypertension uncomplicated

2.6

107.6

760

1690

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

107.5

131

AN4

Balloon angioplasty and drug eluding stent

+∞

106.7

130

E83.51

ICD-10 Finland

Hypocalcemia

24.4

106.7

117

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

26.8

106.4

114

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

746.8

106.3

132

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

106.2

3027

11159

I48.2

ICD-10 Finland

Chronic atrial fibrillation

255.1

106.2

136

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

105.6

4166

16584

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

55.7

105.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

24.2

105.5

116

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

105.5

1338

3845

C07AB12

ATC

nebivolol; oral

5.8

105.3

247

240

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

29.5

105.1

110

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

20.7

105.1

121

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

105.0

1924

6266

Z01.2

ICD-10 Finland

Dental examination

1.4

105.0

7793

35238

M10.9

ICD-10 Finland

Gout, unspecified

3.6

104.8

418

654

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

11.8

104.7

151

IGP01

NOMESCO Finland

Psychiatric family contact

22.2

104.7

118

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

104.5

584

1141

B03XA02

ATC

darbepoetin alfa; parenteral

112.9

104.0

140

L08

ICPC

Shoulder symptom/complaint

1.7

103.8

2722

9815

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

103.4

126

WVA30, ,

SPAT

2.6

103.4

714

1569

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

366.1

102.9

130

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

36.2

102.7

103

S06.0

ICD-10 Finland

Concussion

2.0

102.7

1339

3886

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.6

102.4

307

381

K84

ICPC

Heart disease other

17.2

101.9

125

N05AA01

ATC

chlorpromazine; systemic, rectal

110.4

101.6

137

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

101.5

834

1997

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.4

101.4

319

413

K08.3

ICD-10 Finland

Retained dental root

2.6

101.4

724

1618

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

710.2

101.4

126

IBA01, ,

SPAT

4.3

101.3

323

423

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

101.1

3915

15495

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

6.0

101.0

231

218

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

101.0

1642

5143

C09DA06

ATC

candesartan and diuretics; oral

3.1

101.0

516

955

A10AB06

ATC

insulin glulisine; parenteral

+∞

100.9

123

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

+∞

100.9

123

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.5

100.9

779

1810

C05AA08

ATC

fluocortolone; rectal, topical

2.0

100.6

1331

3883

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

20.0

100.5

117

J45

ICD-10 Finland

Asthma

2.0

100.5

1403

4172

K90

ICPC

Stroke/cerebrovascular accident

28.4

100.4

106

Z94.0

ICD-10 Finland

Kidney transplant status

35.5

100.4

101

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.7

100.3

387

591

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

17.9

100.2

121

L12

ICPC

Hand/finger symptom/complaint

1.7

99.9

2360

8267

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

99.8

487

875

SPAT1284

SPAT

Extensive health certificate

4.1

99.7

345

484

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7253

26644

1.92

322.83

3.6

2.3

0.05

0.04

estimate

0.28

1878

5003

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3689

10523

2.23

322.53

1.4

1.3

8.76

10.68

u/ml

0.95

1601

4699

(3007853) Bacteria identified in Skin by Aerobe culture

2248

5112

2.69

316.47

1.9

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

489

272

10.33

312.71

1.2

1.1

2156.73

8.97

iu/ml

0.53

128

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1540

2843

3.24

308.81

3.1

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2380

4416

3.35

307.65

2.0

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

823

768

6.26

307.65

3.3

1.4

111.54

34.57

ng/l

13.64

721

663

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

447

171

15.00

307.65

3.3

2.4

0.96

0.84

nmol/l

1.07

354

159

(3013115) Eosinophils [#/volume] in Blood

9486

28863

2.94

307.65

7.4

4.9

0.20

0.19

e9/l

4.47

8548

26051

(3024561) Albumin [Mass/volume] in Serum or Plasma

7229

14691

4.09

307.65

5.6

3.1

36.96

38.26

g/l

67.11

6834

13820

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4148

11477

2.36

307.65

2.4

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

3217

7755

2.64

307.65

1.5

1.3

522.82

552.06

titre

0.32

682

1481

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1154

1304

5.25

307.65

9.6

5.2

24.57

24.68

mmol/l

0.42

1147

1299

(3005719) IgG [Mass/volume] in Serum or Plasma

1709

3138

3.28

307.65

3.0

2.3

10.54

10.89

g/l

2.85

1574

2918

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3016

3860

5.11

307.65

2.8

1.6

2.45

2.52

g/l

7.24

2759

3585

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3993

11590

2.22

307.65

1.4

1.3

27.43

29.69

iu/ml

0.12

1094

3536

(3027801) Oxygen [Partial pressure] in Arterial blood

1615

1580

6.22

307.65

10.2

4.9

12.92

14.30

kpa

10.01

1559

1512

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5662

12194

3.42

307.65

3.4

1.4

53.32

11.98

ng/l

2.30

2994

4004

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7640

12406

5.50

307.65

8.3

2.8

1.21

1.22

mmol/l

18.50

7155

11341

(3019198) Lymphocytes [#/volume] in Blood

9463

28700

2.94

307.65

7.2

4.9

1.98

1.97

e9/l

0.19

8606

26178

(3035637) Corticotropin [Mass/volume] in Plasma

574

290

11.43

307.65

1.9

1.4

41.36

53.00

ng/l

0.44

569

290

(3022096) Basophils/Leukocytes in Blood

8349

25007

2.73

307.65

7.3

5.1

0.69

0.23

7871

23652

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1130

1364

4.90

307.65

1.8

1.5

0.28

mg/l

0.01

469

658

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14512

61644

3.38

307.65

6.6

2.4

38.84

35.29

mmol/mol

307.65

13881

59142

(3033658) Prothrombin time (PT) actual/Normal

4080

9496

2.86

307.65

4.4

2.2

95.66

96.91

2.47

3945

9238

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3096

5373

3.73

307.65

2.9

1.5

2.41

2.40

mmol/l

7.13

2785

4770

(3014576) Chloride [Moles/volume] in Serum or Plasma

1974

2367

5.16

307.65

9.5

3.7

104.52

105.05

mmol/l

4.04

1974

2367

(36304419) Bacteria [Presence] in Urine

4228

11155

2.50

307.65

3.2

2.0

0.00

0.07

estimate

—

(3012516) Albumin [Mass/volume] in Urine

4889

6081

5.94

307.65

4.2

1.8

57.71

69.07

mg/l

1.25

3220

3140

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

386

25.39

307.65

2.6

2.1

163.29

86.55

ug/min

0.68

269

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16170

78809

5.33

307.65

13.1

5.4

27.76

25.68

u/l

31.21

15869

76710

(3008152) Bicarbonate [Moles/volume] in Arterial blood

870

843

6.04

307.65

8.6

4.0

24.28

24.26

mmol/l

0.05

832

796

(3020779) Urea [Moles/volume] in Serum or Plasma

1424

1293

6.64

307.65

10.7

3.2

8.10

6.00

mmol/l

23.91

1372

1233

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16228

77750

6.46

307.65

19.1

5.6

73.82

71.18

umol/l

19.88

16085

76582

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1615

1581

6.22

307.65

10.2

4.9

5.09

4.96

kpa

4.21

1559

1511

(3009343) pH of Capillary blood

1144

1399

4.84

307.65

4.2

2.8

7.41

1.50

971

1080

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

371

23.57

307.65

6.1

2.2

0.32

0.30

iu/ml

0.21

206

(3009214) Lutropin [Units/volume] in Serum or Plasma

1628

2683

3.65

307.65

1.6

1.3

8.29

7.81

u/l

0.60

1305

2228

(3014111) Lactate [Moles/volume] in Serum or Plasma

1402

1581

5.32

307.65

9.9

4.2

1.32

mmol/l

0.05

1378

1551

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7035

25512

1.94

307.65

2.1

1.5

1.48

1.27

mmol/l

48.80

6006

23104

(3015377) Calcium [Moles/volume] in Serum or Plasma

6172

10945

4.41

307.65

3.5

1.5

2.33

2.35

mmol/l

14.12

5769

10045

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10454

34044

2.91

307.65

4.0

2.5

89.85

71.10

ug/l

29.48

9973

32740

(3016502) Oxygen saturation in Arterial blood

1450

1292

6.78

307.65

10.8

5.3

96.18

96.38

0.35

1403

1239

(3027945) Reticulocytes/Erythrocytes in Blood

1679

2076

4.92

307.65

3.2

1.8

1.76

1.42

33.20

1512

1863

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1606

2717

3.55

307.65

1.9

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

16390

48468

43.33

307.65

11.9

2.2

15.20

14.13

pmol/l

307.65

15973

44913

(3026008) Bacteria identified in Urine by Culture

4496

12505

2.38

307.65

2.6

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

10017

30080

3.15

307.65

10.7

5.0

3.96

3.88

e9/l

2.66

8907

26378

(3001604) Monocytes [#/volume] in Blood

9198

27553

2.93

307.65

7.2

5.0

0.55

0.53

e9/l

17.50

8175

24608

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15641

71570

4.39

307.65

15.9

5.7

18.57

21.55

mg/l

26.98

13199

52004

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3808

6374

4.03

307.65

1.7

1.4

34412280.41

51873018.64

pmol/l

0.76

3307

5714

(3000991) Gas panel - Venous blood

1395

1512

5.54

307.65

11.4

4.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4946

6138

5.98

307.65

5.0

2.0

9.88

11.18

mg/mmol

0.69

3230

3187

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4936

8904

3.98

307.65

2.4

1.5

191.83

207.92

u/l

0.29

4710

8484

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6003

15714

2.77

307.65

1.5

1.2

1.60

1.96

u/ml

1.31

1959

4872

(3002032) Base excess in Venous blood by calculation

1551

1804

5.20

307.65

5.3

2.3

1.55

1.88

mmol/l

2.61

1346

1578

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1773

1510

7.23

307.65

4.2

2.5

71.28

66.09

ng/l

0.93

1590

1382

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8607

20043

3.89

307.65

6.6

2.5

10.17

11.43

umol/l

12.79

8124

18788

(3009261) Glucose [Presence] in Urine by Test strip

9325

34154

2.19

307.65

3.8

2.6

0.05

0.00

estimate

1.23

2118

6031

(3023103) Potassium [Moles/volume] in Serum or Plasma

15645

64742

6.37

307.65

17.5

4.3

3.93

mmol/l

1.20

15334

62449

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4219

9843

2.87

307.65

2.1

1.4

0.96

0.82

mg/l

1.63

3138

7213

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1180

1436

4.87

307.65

4.3

2.8

5.12

5.09

kpa

0.43

1136

1381

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3024

7852

2.41

307.65

2.0

1.4

1.44

1.18

74.74

2714

7289

(3020630) Protein [Mass/volume] in Serum or Plasma

1141

1398

4.83

307.65

3.0

1.3

66.50

68.64

g/l

13.27

1073

1310

(3029937) Albumin [Presence] in Urine by Test strip

5316

16569

2.17

307.65

3.9

2.6

0.00

estimate

0.10

2111

5814

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3011

3193

6.22

307.65

4.2

1.8

0.82

0.86

mmol/l

27.85

2860

2991

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1786

2149

5.09

307.65

5.3

2.0

228.79

218.11

u/l

2.70

1708

2038

(3004119) Hemoglobin [Mass/volume] in Venous blood

968

1044

5.45

307.65

4.5

1.8

131.98

141.30

g/l

22.92

944

1021

(3019069) Monocytes/Leukocytes in Blood

8385

25059

2.75

307.65

7.3

5.1

8.49

8.41

1.79

7919

23801

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3428

3436

6.76

307.65

3.4

1.3

784.37

181.89

ng/l

14.45

2739

2491

(3028707) Methadone [Presence] in Urine by Screen method

787

441

10.43

307.65

2.9

1.8

—

(3002030) Lymphocytes/Leukocytes in Blood

8694

26629

2.72

307.65

7.2

4.9

29.67

31.01

26.30

8299

25561

(40758558) Short blood count panel - Blood

5178

14164

2.51

307.65

6.8

3.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5063

3942

9.87

307.65

1.3

1.2

215.97

98.06

u/ml

43.31

2348

1446

(3009508) Creatinine [Moles/volume] in Urine

5865

8811

5.19

307.65

4.1

1.8

8.25

8.99

mmol/l

15.86

5158

7943

(3018095) Leukocytes [#/volume] in Urine

6032

18350

2.31

307.65

4.0

2.5

66.59

65.97

e6/l

0.03

4218

11077

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5608

15150

2.61

307.65

3.6

2.2

3.34

1.86

e6/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5683

13260

3.12

307.65

3.2

1.7

54.83

59.10

u/l

4.74

5281

12407

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2729

3359

5.24

307.65

2.9

1.7

23.88

27.45

22.55

2515

3133

(3021601) Nitrite [Presence] in Urine by Test strip

9201

33492

2.19

307.65

3.8

2.5

0.00

estimate

3.74

2216

6077

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1029

1015

5.98

307.65

2.3

1.3

7.83

3.21

ug/l

5.94

915

884

(3024354) Oxygen [Partial pressure] in Venous blood

1298

1613

4.80

307.65

4.9

2.2

4.74

4.72

kpa

0.08

1261

1579

(3035350) Ketones [Presence] in Urine by Test strip

9296

33894

2.20

307.65

3.8

2.5

6.62

1.86

estimate

1.49

2231

6063

(3019309) Folate [Moles/volume] in Red Blood Cells

2611

3005

5.58

307.65

1.8

1.5

1171.59

1144.24

nmol/l

0.62

2079

2240

(3023368) Bacteria identified in Blood by Culture

3774

7508

3.34

307.65

4.5

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12498

38424

4.24

307.65

8.7

4.0

75.31

71.22

u/l

24.12

11945

36247

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1549

1582

5.94

307.65

4.3

1.7

1.22

1.23

mmol/l

7.86

1337

1311

(3001019) Free T4 and TSH panel - Serum or Plasma

2555

4782

3.35

307.65

2.5

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8573

14726

5.63

307.65

8.9

3.0

1.21

1.22

mmol/l

44.25

7412

12829

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

844

756

6.53

307.65

12.9

5.7

16.51

16.88

1.86

816

716

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5093

9308

3.96

307.65

2.4

1.8

2.61

2.31

mg/l

21.39

4455

8027

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1679

2813

3.60

307.65

1.8

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7229

16029

3.68

307.65

2.1

1.4

97.81

98.89

pmol/l

1.01

4203

8453

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

839

773

6.34

307.65

12.7

6.3

24.10

24.20

mmol/l

0.28

824

759

(3042936) Bacteria identified in Isolate by Culture

2283

5110

2.74

307.65

2.2

1.5

—

(3019977) pH of Arterial blood

1621

1588

6.22

307.65

10.3

4.8

7.41

7.42

3.55

882

876

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1594

2033

4.74

307.65

2.6

2.3

0.23

g/l

3.52

1486

1933

(3032080) INR in Blood by Coagulation assay

6359

12496

3.98

307.65

9.7

2.0

1.11

1.02

inr

60.68

5346

9955

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8887

23841

3.31

307.65

2.8

2.0

73.03

75.35

nmol/l

11.28

8355

22646

(3000850) Epithelial cells [#/volume] in Urine

3576

8499

2.72

307.65

2.8

1.8

6.81

6.63

e6/l

0.23

3280

7514

(3002582) Erythrocytes [#/volume] in Urine

5058

13437

2.59

307.65

3.5

2.1

73.26

62.60

e6/l

0.17

3908

9535

(3021387) Prolactin [Units/volume] in Serum or Plasma

1922

3869

3.01

307.65

2.1

1.5

333.87

264.64

mu/l

7.99

1716

3552

(3044889) 12 lead EKG panel

10826

34227

3.18

307.65

3.7

1.8

0.50

0.43

0.19

(3018418) pH of Serum or Plasma

5391

7626

5.36

307.65

5.3

1.9

7.39

7.40

0.73

3929

4983

(3019225) pH of Specimen

1513

2510

3.61

307.65

4.9

2.0

7.35

7.32

3.28

1164

1511

(4035726) Immunohistochemistry procedure

1309

1432

5.46

307.65

1.5

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1594

1840

5.25

307.65

5.3

2.3

5.85

5.86

kpa

0.07

1549

1798

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

938

197

28.17

307.65

7.4

1.2

83.82

140.21

u/ml

0.39

399

(3031040) Bacteria [#/volume] in Urine by Automated count

10718

39043

2.49

307.65

4.5

2.9

1588.66

1446.88

e6/l

0.09

155

393

(3006504) Eosinophils/Leukocytes in Blood

8358

25031

2.73

307.65

7.2

5.1

2.91

2.90

0.03

7893

23737

(3022948) Iron [Moles/volume] in Serum or Plasma

3272

4501

4.81

307.65

2.8

1.6

14.35

21.36

umol/l

0.93

3049

4248

(3030467) Casts [#/volume] in Urine by Automated count

4371

11211

2.60

307.65

3.3

2.0

0.26

0.25

e6/l

0.13

3250

7451

(3013512) EKG study

4912

9973

3.49

307.65

3.3

1.6

0.73

0.79

0.12

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3167

2644

8.03

307.65

2.9

1.6

370.13

384.14

nmol/l

2.25

2933

2497

(3023520) Reticulocytes [#/volume] in Blood

1222

1250

5.82

307.65

3.0

1.7

73.45

64.17

e9/l

11.27

903

887

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4377

1887

17.22

307.65

4.9

3.0

4.59

4.82

pmol/l

12.68

4011

1742

(3026782) Osmolality of Urine

3160

6982

2.89

307.65

3.0

1.9

529.36

571.76

mosm/kgh2o

15.19

2789

6012

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

14961

64160

3.87

307.65

14.1

4.4

91.68

92.31

ml/min/173m2

3.29

13833

55701

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1374

1235

6.69

307.65

11.1

5.5

125.12

127.56

g/l

2.40

1347

1197

(3003396) Base excess in Arterial blood by calculation

1617

1563

6.30

307.65

10.2

4.8

0.58

0.64

mmol/l

0.19

1306

1174

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16506

61283

36.84

307.65

13.6

2.6

2.13

1.74

mu/l

30.40

16038

57812

(3007164) IgA [Mass/volume] in Serum or Plasma

5014

13244

2.60

307.65

1.6

1.3

2.18

2.13

g/l

1.56

3309

9250

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7965

26666

2.28

307.65

2.9

2.2

—

estimate

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6460

16212

3.00

307.65

3.6

2.2

31.10

28.55

u/l

3.45

6127

15577

(3013826) Glucose [Moles/volume] in Serum or Plasma

9632

24998

3.72

307.65

5.9

2.5

6.63

5.85

mmol/l

169.14

8979

21694

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2584

4752

3.42

307.65

3.8

1.5

275.01

42.56

ng/l

6.23

1589

2066

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2312

3427

4.22

307.65

2.8

1.5

29.57

28.48

11.69

2251

3324

(3018010) Neutrophils/Leukocytes in Blood

8544

26225

2.68

307.65

7.0

4.8

55.89

55.15

7.38

8238

25309

(3019550) Sodium [Moles/volume] in Serum or Plasma

15615

64414

6.29

307.65

17.3

4.2

139.59

139.81

mmol/l

30.30

15334

62385

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1730

1139

9.36

307.65

2.8

2.0

4.73

3.22

iu/l

6.07

928

506

(3044640) Blood type and Crossmatch panel - Blood

5512

16074

2.37

307.65

2.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

471

181

14.96

307.65

7.2

3.0

392.28

398.87

umol/l

0.21

420

151

(3026493) Urate [Moles/volume] in Serum or Plasma

4392

11986

2.42

307.65

2.7

1.6

331.27

317.03

umol/l

16.99

3972

11145

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14733

63533

3.48

307.65

5.1

2.5

5.86

5.35

mmol/l

306.95

13991

60113

(3037467) Urinalysis macro (dipstick) panel - Urine

11268

42956

2.43

307.65

4.6

3.0

1.44

2.51

0.90

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2438

2470

6.29

307.65

7.6

3.4

1.06

1.04

mmol/l

3.00

2298

2199

(40768797) Stomach Pathology biopsy report

2476

5359

2.86

307.65

1.2

1.1

—

(3012544) pH of Venous blood

1589

1852

5.20

307.65

5.5

2.2

7.37

0.14

937

1006

(3021589) Normoblasts [#/volume] in Blood

8064

25432

2.49

307.65

12.2

5.9

0.00

e9/l

0.48

6732

21099

(3021960) Folate [Moles/volume] in Serum or Plasma

4582

8104

3.98

307.65

1.7

1.3

19.47

20.61

nmol/l

5.59

4089

7017

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2055

4297

2.91

307.65

2.7

1.8

6.57

6.23

umol/l

0.32

1758

3742

(3015736) pH of Urine

7446

25748

2.11

307.65

3.3

2.3

6.23

6.19

2.26

4400

15022

(3006315) Basophils [#/volume] in Blood

9214

27561

2.94

307.65

7.2

5.0

0.04

e9/l

2.48

8174

24607

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1035

1202

5.07

307.65

4.1

2.9

1.24

1.01

mmol/l

1.13

745

852

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12637

44405

3.42

307.65

4.6

3.1

9.60

7.28

mm/h

93.38

11996

42182

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

588

454

7.48

303.46

3.1

1.7

7.39

6.74

pmol/l

0.38

588

454

(3004588) Protein electrophoresis panel - Serum or Plasma

858

1029

4.86

298.90

2.5

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

1682

3364

3.00

296.19

4.9

4.1

1.00

0.45

9.08

465

513

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15216

73688

2.71

295.73

5.8

3.2

2.79

3.01

mmol/l

177.73

14549

70869

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14401

68023

2.32

294.71

4.5

2.7

1.37

1.16

mmol/l

138.64

13694

65470

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12089

53508

1.95

293.05

3.9

2.2

42.83

30.44

u/l

59.04

11594

51788

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

673

655

5.95

287.34

1.3

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

1615

3220

3.00

285.43

4.6

3.9

0.69

0.45

1.76

441

520

(3017732) Neutrophils [#/volume] in Blood

2522

6383

2.43

284.68

3.2

1.9

4.31

4.20

e9/l

0.24

2268

5727

(3028026) IgM [Mass/volume] in Serum or Plasma

1321

2330

3.36

283.01

1.9

1.7

1.19

1.27

g/l

1.41

1229

2199

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

728

789

5.35

280.98

5.2

2.2

51.23

47.88

1.94

715

780

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

679

688

5.71

279.39

2.2

1.8

1.38

1.09

g/l

9.19

586

597

(3020891) Body temperature

671

674

5.76

278.31

5.8

2.7

36.97

36.94

°c

0.86

663

668

(3025159) Blasts/Leukocytes in Blood

1658

3410

2.91

277.72

5.1

4.3

0.06

0.01

1.98

374

458

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15129

73570

2.56

275.12

5.3

3.1

4.67

4.95

mmol/l

231.71

14507

71082

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1751

3735

2.81

275.05

6.0

2.4

—

(3021440) Promyelocytes/Leukocytes in Blood

1605

3297

2.91

269.05

5.0

4.1

0.07

0.02

2.55

384

446

(3027273) Bicarbonate [Moles/volume] in Venous blood

672

704

5.52

267.87

4.2

2.1

25.01

25.44

mmol/l

2.12

642

668

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15061

73287

2.49

267.11

5.2

3.0

1.41

1.52

mmol/l

209.62

14379

70648

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

281

28.54

266.12

1.6

1.2

14.44

13.97

pmol/l

0.29

239

(3015235) Bicarbonate [Moles/volume] in Capillary blood

603

569

6.11

264.42

3.7

1.9

24.22

24.43

mmol/l

0.67

595

561

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

987

1480

3.90

264.26

4.1

1.9

24.64

13.55

ug/l

0.35

750

975

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13763

64715

2.07

260.27

19.7

6.5

13.40

13.13

134.81

13615

63530

(1616796) Gas panel - Central venous blood

469

330

8.15

258.47

3.7

2.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1129

1901

3.49

258.17

1.7

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2562

6820

2.30

256.86

2.9

1.9

0.98

0.87

e6/l

0.73

1317

3296

(3048689) Calprotectin [Mass/mass] in Stool

3151

9262

2.11

248.28

2.3

3.1

121.11

107.86

ug/g

1.12

2471

7548

(3023323) Follitropin [Units/volume] in Serum or Plasma

2086

5129

2.46

247.85

1.5

1.3

19.59

24.50

iu/l

9.16

1750

4517

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2402

6334

2.31

245.11

3.1

1.9

3.58

3.25

e6/l

0.58

1136

2810

(3023183) Ammonium ion [Moles/volume] in Plasma

408

254

9.19

243.66

3.3

2.8

34.31

35.07

umol/l

0.16

375

231

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

575

570

5.81

241.11

2.5

1.8

410.78

449.60

ug/l

0.11

535

516

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

511

454

6.47

235.74

2.3

1.5

1.67

1.55

ug/l

0.11

459

390

(36660697) Celiac disease serology panel - Serum

2039

5090

2.41

233.84

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

787

1089

4.19

232.42

1.7

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1629

3663

2.65

230.37

2.6

1.8

34.28

42.59

u/l

2.27

1367

3156

(3021901) Oxygen saturation in Capillary blood

387

249

8.88

226.28

3.3

2.1

92.17

92.80

0.66

376

244

(3011985) Renin [Units/volume] in Plasma

375

232

9.23

224.78

2.4

1.7

76.17

51.09

mu/l

0.79

346

215

(3003181) Sodium [Moles/volume] in Urine

310

141

12.52

220.15

2.0

1.5

69.16

74.57

mmol/l

0.44

255

115

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

611

708

4.97

219.95

6.8

2.5

1.65

1.58

0.66

584

664

(3018405) Lactate [Moles/volume] in Arterial blood

456

384

6.80

219.70

4.9

2.8

1.32

1.38

mmol/l

0.37

449

378

(3036489) Thrombin time

773

1110

4.04

217.97

2.7

1.6

20.62

19.84

2.42

648

926

(3041096) Erythrocytes [Presence] in Urine by Automated

5549

20606

1.76

213.66

3.1

2.1

0.08

0.09

estimate

0.05

1878

4910

(3008295) Osmolality of Serum or Plasma

299

135

12.60

213.08

1.9

1.4

285.78

285.74

mosm/kgh2o

0.01

242

108

(3011397) Hemoglobin [Presence] in Urine by Test strip

3996

13429

1.87

212.47

3.7

2.6

0.14

0.20

0.14

101

(3000570) Elastase.pancreatic [Mass/mass] in Stool

582

677

4.95

208.58

1.5

1.2

296.47

357.10

ug/g

5.82

310

326

(3012501) Base excess in Blood by calculation

415

334

7.10

207.14

3.7

1.9

2.16

1.70

mmol/l

2.40

267

190

(3002256) Pathology report gross observation

2166

5849

2.23

206.76

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

4133

14158

1.84

206.08

3.9

2.4

1.02

1.37

kg/l

1.08

2736

8692

(40761536) Microorganisms panel - Urine sediment

1762

4400

2.39

200.21

3.5

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

686

963

4.11

198.72

3.5

1.7

95.10

93.16

1.08

655

904

(3017143) Hepatitis C virus Ab [Presence] in Serum

3198

10198

1.93

196.81

1.8

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

549

640

4.93

196.23

7.3

2.7

0.91

0.92

0.38

524

601

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1258

2686

2.75

194.71

1.2

1.1

17.59

8.26

u/ml

0.25

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2148

5971

2.16

190.17

3.5

1.8

11.71

14.48

nmol/l

39.23

1971

5733

(3011288) Drugs identified in Urine by Screen method Nominal

1168

2430

2.82

189.25

3.0

1.5

—

(3022145) Colonoscopy Study observation

1989

5369

2.22

188.94

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

343

243

8.04

187.94

1.2

31.27

35.90

nmol/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

652

923

4.07

186.81

4.1

3.1

24.61

24.51

mmol/l

0.38

608

882

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

245

14.33

185.36

2.0

3.6

—

(3024928) Oxygen saturation in Venous blood

421

401

6.00

182.73

4.7

1.7

62.68

62.79

0.03

411

395

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

327

229

8.13

180.60

1.6

1.4

—

(3007461) Platelets [#/volume] in Blood

16573

87486

6.92

179.99

26.2

8.3

262.75

256.73

e9/l

29.10

16432

85507

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

689

1057

3.76

178.02

5.0

2.7

1.36

1.03

mg/l

24.64

641

999

(3015171) Extractable nuclear Ab [Units/volume] in Serum

983

1916

2.99

177.91

1.3

0.56

0.76

u/ml

0.25

109

(3035941) MCH [Entitic mass]

16574

87597

6.83

175.77

26.0

8.3

30.10

30.11

0.36

16507

86740

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16574

87598

6.83

175.73

26.0

8.3

90.16

89.81

21.14

16507

86732

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16574

87611

6.82

175.19

26.7

8.4

41.33

42.97

3.65

16507

86653

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

753

1249

3.49

174.70

2.1

1.9

0.23

0.22

g/l

4.87

716

1197

(3026361) Erythrocytes [#/volume] in Blood

16574

87628

6.80

174.49

26.1

8.3

4.57

4.62

e12/l

45.34

16405

85461

(3010813) Leukocytes [#/volume] in Blood

16575

87664

6.79

173.40

26.2

8.3

6.73

6.44

e9/l

54.67

16403

85468

(3000963) Hemoglobin [Mass/volume] in Blood

16575

87698

6.75

171.99

26.3

8.4

136.68

138.89

g/l

86.78

16510

86849

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

378

341

6.32

171.94

4.3

1.5

32.60

22.03

mg/l

4.28

323

294

(3028626) Oxygen [Partial pressure] in Capillary blood

509

627

4.65

171.36

4.3

3.9

8.97

9.36

kpa

3.56

498

612

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

767

1306

3.40

171.30

2.1

1.9

1.20

1.12

g/l

7.69

732

1254

(3034860) Kappa light chains.free [Mass/volume] in Serum

376

344

6.23

168.99

4.3

1.5

40.99

28.42

mg/l

2.85

320

297

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

628

936

3.86

168.43

3.0

2.0

173.81

161.12

2.40

591

867

(3000494) Fungus identified in Specimen by Culture

2212

6506

2.04

168.03

1.5

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1298

3035

2.51

167.98

2.9

1.5

72.19

84.49

ml/min/173m2

19.36

549

1013

(4146454) Self-monitoring of blood glucose

167

36.30

166.59

3.4

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

369

336

6.26

166.51

2.9

1.5

611.38

50949.82

u/ml

0.48

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

305

221

7.85

164.46

1.6

1.2

1082.87

308.80

pmol/l

1.00

263

194

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

461

542

4.87

163.15

5.2

1.9

327.80

686.93

iu/ml

0.39

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

335

280

6.81

162.23

4.2

1.4

1.79

1.23

ratio

1.48

195

153

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

825

1527

3.13

162.13

1.7

1.5

0.44

0.51

nmol/l

0.71

681

1281

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

884

1729

2.97

158.72

2.1

2.0

40.09

40.98

u/l

0.60

819

1667

(3023420) DNA double strand Ab [Units/volume] in Serum

981

2082

2.74

152.56

2.2

1.8

7.18

6.68

iu/ml

0.16

256

491

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

435

516

4.82

152.46

1.3

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

748

1363

3.17

150.51

1.6

1.7

8.45

13.46

iu/ml

0.86

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

649

1077

3.47

150.22

2.0

1.6

452.27

352.61

mu/l

1.42

536

897

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

177

19.24

150.03

3.8

1.2

23.75

14.65

u/ml

2.13

171

(3020961) Endomysium IgA Ab [Titer] in Serum

1424

3659

2.29

149.95

1.2

1.1

136.48

171.64

titre

0.32

138

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1240

3012

2.41

147.67

2.8

1.7

0.29

0.24

e6/l

0.46

1186

2824

(3003694) ABO and Rh group [Type] in Blood

5849

23732

1.58

146.56

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

648

1099

3.39

145.29

1.5

1.2

18.14

20.23

u/l

0.85

537

927

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

446

568

4.49

144.57

1.8

1.2

—

(3047181) Lactate [Moles/volume] in Blood

462

610

4.33

143.67

7.6

2.5

1.33

1.16

mmol/l

2.37

406

533

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

823

1638

2.91

143.23

1.6

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

663

4.16

142.78

2.5

1.2

7.18

6.98

g/l

1.26

459

617

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

663

4.16

142.78

2.5

1.2

4.28

4.25

g/l

0.23

459

618

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

481

662

4.16

142.38

2.5

1.2

3.56

3.63

g/l

0.57

459

617

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

302

263

6.53

141.44

1.4

0.12

0.11

nmol/l

—

(3034770) Mitochondria Ab [Titer] in Serum

661

1164

3.27

140.09

1.3

1066.11

1496.49

titre

0.53

(3007566) Smooth muscle Ab [Titer] in Serum

677

1216

3.20

139.18

1.3

1.4

103.11

132.56

titre

0.29

117

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

457

616

4.24

138.68

1.8

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

677

1226

3.18

137.41

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

637

1109

3.30

137.32

3.5

1.9

3.61

3.63

g/l

0.12

601

1053

(3014051) Protein [Presence] in Urine by Test strip

5059

20102

1.59

136.00

2.8

2.1

0.06

0.03

0.41

239

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

298

268

6.32

135.86

1.4

0.50

nmol/l

0.12

288

255

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

463

644

4.11

135.27

2.6

1.2

2.77

2.70

g/l

0.56

441

598

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1914

5799

1.96

131.83

2.6

2.2

6499.01

7170.72

u/l

0.36

752

2735

(3010838) Calcium [Moles/time] in 24 hour Urine

451

635

4.06

129.79

2.3

2.0

5.28

5.74

mmol/24h

1.82

410

602

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

272

236

6.54

127.77

1.4

1.3

—

nmol/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

378

472

4.56

125.23

1.1

117.07

116.59

0.09

337

405

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

259

218

6.74

124.71

1.4

1.3

0.21

0.17

nmol/l

0.50

186

167

(3039000) Anion gap in Blood by calculation

293

292

5.70

122.00

10.1

3.6

11.39

11.48

mmol/l

0.13

270

256

(3018572) Chloride [Moles/volume] in Blood

293

5.68

121.61

10.1

3.6

105.49

105.42

mmol/l

0.08

271

257

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

468

718

3.72

120.58

2.0

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

406

558

4.15

120.32

2.7

1.3

0.38

0.11

g/l

2.49

372

501

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

566

4.12

120.20

2.5

1.2

9.56

10.31

g/l

3.08

384

517

(3045414) Leukocytes [Presence] in Urine

1584

4635

2.01

119.56

2.0

1.6

0.03

0.04

estimate

0.19

395

1234

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

561

995

3.23

117.43

2.3

2.1

9.98

9.88

mg/l

0.12

534

959

(3037756) Immunofixation for Serum or Plasma

235

189

7.04

117.29

1.9

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

408

576

4.04

116.99

1.3

1.2

3.29

4.95

u/ml

0.71

214

274

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

580

1054

3.15

116.91

1.3

1.2

473.47

426.17

mg/l

1.65

560

1012

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

731

1528

2.75

116.35

1.3

25.16

40.30

u/ml

0.78

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

286

293

5.54

116.06

1.4

1.2

22.54

13.55

u/l

0.97

257

267

(4198724) Urine methamphetamine measurement

166

12.02

115.99

2.0

4.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1128

2921

2.25

115.67

2.3

1.6

38.59

43.27

nmol/l

5.91

1107

2897

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

154

13.80

114.85

1.8

1.19

0.97

nmol/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

290

306

5.38

114.41

1.8

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5767

24313

1.50

113.72

2.3

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

421

623

3.85

113.72

1.3

1.2

3.49

3.45

u/ml

0.01

172

247

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

192

121

8.97

113.70

8.9

4.3

11.08

9.31

mg/l

3.27

180

109

(3016244) Insulin [Units/volume] in Serum or Plasma

303

338

5.09

113.14

2.7

3.6

27.70

24.87

mu/l

0.45

289

314

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

365

486

4.27

112.33

2.5

1.2

0.02

0.00

g/l

0.38

345

457

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

530

933

3.25

112.19

1.4

1.2

1836.73

583.67

e6/l

0.52

424

744

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

527

925

3.26

112.05

1.4

1.2

30.14

10.61

e6/l

1.11

398

709

(3042111) Morphology [Interpretation] in Bone marrow Narrative

195

129

8.55

111.91

1.6

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

345

443

4.43

110.74

2.6

1.2

0.00

g/l

0.08

317

405

(3052851) Hemolysis interference index of Serum or Plasma

457

743

3.51

108.69

2.9

1.9

1.64

2.60

index

1.07

244

345

(4195642) Thrombophilia screening test

370

514

4.10

108.21

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

1591

4825

1.93

108.09

1.4

1.3

230.09

235.04

u/ml

0.03

1481

4542

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

843

1975

2.46

107.48

2.5

1.6

192.49

212.53

pmol/l

4.87

806

1927

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

521

933

3.19

107.40

1.2

3.73

3.43

mmol/l

7.90

495

889

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

398

595

3.81

106.08

1.1

1.0

—

(3000012) Reticulocyte production index

190

132

8.14

105.52

2.1

1.2

0.95

0.81

1.45

126

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

677

1431

2.72

105.46

1.4

1.3

6.31

10.04

u/ml

0.43

136

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1770

5616

1.85

104.87

4.7

2.8

30.79

32.15

5.29

1346

4046

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4860

20041

1.50

104.40

1.9

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

327

423

4.39

104.07

2.6

1.2

0.00

g/l

-0.00

317

404

(3020911) Cortisol [Moles/time] in 24 hour Urine

153

11.21

103.22

1.5

1.2

288.77

85.00

nmol/24h

0.58

153

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1464

4380

1.95

103.19

2.4

2.3

18.97

20.17

au/ml

0.25

169

787

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

674

1438

2.69

103.18

1.4

1.3

11.46

10.79

u/ml

0.06

202

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

183

126

8.21

102.26

1.8

1.4

5.55

1.48

nmol/l

1.71

149

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

124

+∞

101.76

2.5

0.0

146.62

—

nmol/l

—

115

(3006184) Hemoglobin [Mass/volume] in Capillary blood

409

649

3.59

100.61

2.5

2.0

133.51

136.20

g/l

1.52

339

528

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1215

3429

2.06

100.32

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

403

648

3.54

97.32

2.8

2.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

199

165

6.82

97.01

2.7

2.5

1.62

1.59

g/24h

0.03

129

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1359

4045

1.96

96.95

1.3

46.48

49.22

au/ml

0.15

312

(3000034) Microalbumin [Mass/volume] in Urine

170

114

8.42

96.71

3.6

1.5

42.83

59.03

mg/l

0.29

126

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

595

1231

2.77

96.30

1.3

1.2

52.37

46.41

u/ml

0.26

105

(3037121) Protein [Mass/volume] in Urine

567

1144

2.84

95.95

3.9

3.1

544.75

499.46

mg/l

0.10

291

471

(3013139) Helicobacter pylori Ag [Presence] in Stool

1344

4001

1.96

95.79

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

558

1134

2.81

93.22

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

157

100

8.86

92.38

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

271

332

4.63

91.70

1.1

97.22

94.26

0.79

254

302

(3016879) Cocaine [Presence] in Urine

1440

4466

1.88

90.84

2.3

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

136

10.80

89.99

3.8

1.4

164.03

105.66

umol/l

0.67

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

545

1116

2.79

89.81

1.3

2.61

7.69

u/ml

0.74

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

266

327

4.61

89.67

1.5

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

469

883

3.03

89.21

1.4

1.2

—

(4268621) Lupus anticoagulant assay

308

432

4.05

89.03

2.3

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

273

348

4.45

88.38

1.5

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

544

1123

2.77

88.35

1.5

1.2

—

(3025941) Bacteria identified in Stool by Culture

1230

3648

1.96

88.34

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

697

3.30

88.10

1.5

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

332

502

3.76

87.18

1.4

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

427

771

3.15

86.84

1.5

1.6

0.66

0.77

g/l

1.49

315

629

(3008037) Lactate [Moles/volume] in Venous blood

299

419

4.05

86.53

3.7

1.6

1.52

1.29

mmol/l

3.40

290

412

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

532

1099

2.77

86.28

1.3

1.2

31.26

22.29

u/ml

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

248

298

4.71

85.72

1.6

1.4

72.87

72.46

0.13

233

284

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

363

594

3.47

85.52

3.7

2.9

348.55

81.25

u/ml

0.87

306

514

(3004809) Band form neutrophils/Leukocytes in Blood

246

295

4.72

85.21

3.0

1.8

1.39

1.41

0.03

229

265

(3002079) Sodium [Moles/time] in 24 hour Urine

144

8.92

85.17

1.3

1.5

164.68

146.15

mmol/24h

1.12

144

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

234

268

4.94

85.09

1.1

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

607

1356

2.56

84.95

1.3

1.2

33.89

38.69

u/ml

0.25

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

317

472

3.81

84.94

1.4

20.15

3.36

u/ml

—

(3045142) Bone marrow Pathology biopsy report

137

9.54

84.44

1.4

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

215

229

5.31

84.10

1.5

1.2

—

(3016750) Collection duration of Urine

19.21

84.00

2.1

2.4

498.60

525.79

min

0.81

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

243

292

4.71

83.99

1.6

1.4

591.29

510.39

mu/l

0.24

228

278

(3016650) Hepatitis A virus Ab [Presence] in Serum

437

825

3.02

82.74

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

532

1130

2.69

81.98

1.5

1.2

13.94

22.38

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

574

1271

2.58

81.71

1.3

1.2

257.21

225.03

u/ml

1.65

337

804

(3006653) Thiamine [Moles/volume] in Blood

145

100

8.18

80.98

1.4

1.2

136.41

131.74

nmol/l

0.45

145

100

(3000764) Benzodiazepines [Presence] in Urine

1519

5002

1.77

78.64

2.3

1.3

—

(3016038) Potassium [Moles/volume] in Urine

124

9.98

78.55

2.3

1.5

32.82

36.25

mmol/l

0.47

115

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

286

422

3.84

77.56

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

911

2538

2.07

77.30

1.4

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1050

3085

1.97

77.14

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

210

239

4.97

76.89

1.5

1.3

—

(3027008) Opiates [Presence] in Urine

1522

5057

1.75

76.33

2.3

1.3

—

(3028300) Cannabinoids [Presence] in Urine

1526

5077

1.75

76.18

2.3

1.3

—

(3042517) Benzodiazepines panel - Urine

41.59

75.64

4.1

1.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

455

927

2.80

75.62

1.7

1.4

4.26

7.73

iu/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

500

1075

2.65

75.29

1.5

1.2

147.17

146.71

au/ml

0.02

117

290

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

318

520

3.47

75.01

1.4

1.2

5.92

6.48

umol/l

1.47

295

465

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

356

629

3.21

74.88

1.5

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

329

559

3.34

73.41

1.3

1.2

473.33

396.11

titre

0.14

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1165

3624

1.86

72.21

2.1

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

830

2310

2.06

70.50

1.6

1.7

11.11

10.45

u/ml

0.19

207

850

(3042733) HLA Ab [Presence] in Serum

20.44

69.29

4.9

2.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

68.25

68.69

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

854

2426

2.02

68.67

2.0

1.5

0.03

estimate

0.06

322

1044

(3027944) Amphetamines [Presence] in Urine

1490

5067

1.71

68.54

2.3

1.3

—

(21494434) Karyotype in Bone marrow

106

10.29

68.38

1.2

1.1

—

(3024471) HLA-A [Type]

20.88

68.00

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3889

16432

1.42

67.79

2.3

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

579

1411

2.34

67.55

2.2

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

204

256

4.50

67.29

1.5

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

196

238

4.65

67.05

1.9

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

116

8.48

66.51

2.8

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

154

148

5.87

66.38

2.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

154

148

5.87

66.38

2.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

154

148

5.87

66.38

2.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

401

819

2.78

66.35

1.1

1.0

—

(3024932) HLA-DR beta [Type]

21.89

65.45

1.1

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

197

247

4.50

65.05

1.6

1.2

1.20

1.50

promille

1.35

158

201

(3024139) IgG subclass 3 [Mass/volume] in Serum

272

443

3.48

64.56

1.5

1.3

0.36

0.43

g/l

1.09

182

330

(3028192) IgG subclass 2 [Mass/volume] in Serum

272

443

3.48

64.56

1.4

1.3

2.87

3.19

g/l

1.82

183

328

(3027135) IgG subclass 1 [Mass/volume] in Serum

272

444

3.47

64.36

1.4

1.3

6.72

6.69

g/l

0.04

181

328

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4191

18089

1.40

64.06

2.4

2.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

526

1258

2.38

63.90

2.0

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

110

8.60

63.67

1.2

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

208

280

4.20

63.28

1.4

1.1

—

(4062490) Immunoglobulin typing, IgG

269

441

3.45

63.26

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

104

9.14

62.61

1.8

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

185

227

4.60

62.59

1.2

61.08

62.43

u/l

0.10

162

200

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

206

280

4.16

61.96

4.0

3.0

265.30

17.88

u/ml

1.27

191

257

(3035715) Granulocytes [#/volume] in Blood

395

838

2.68

60.99

3.0

3.4

3.88

3.71

e9/l

0.88

395

838

(3003434) Protein [Mass/volume] in Pleural fluid

115

7.53

60.73

1.6

1.4

34.30

43.04

g/l

5.78

108

(3000093) Morphology [Interpretation] in Blood Narrative

159

174

5.15

60.65

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1328

4523

1.70

60.44

1.1

1.0

—

(44790049) Parainfluenza type 3 nucleic acid detection

232

355

3.69

60.04

1.7

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

232

355

3.69

60.04

1.7

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

232

356

3.68

59.82

1.7

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

751

2140

2.01

59.78

1.1

6.28

5.87

eliau/ml

0.07

108

389

(44790047) Parainfluenza type 1 nucleic acid detection

232

357

3.67

59.59

1.7

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

320

611

2.97

59.50

1.3

59.66

28.99

u/ml

0.92

(3008757) Leukocyte morphology finding [Identifier] in Blood

167

196

4.81

59.30

3.7

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

166

195

4.80

58.89

1.7

1.5

5.18

5.00

u/l

0.19

140

179

(3011412) CD3 cells [#/volume] in Blood

221

332

3.76

58.62

2.2

2.3

1305.25

1375.87

e6/l

0.52

181

279

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

321

622

2.93

58.23

1.2

17.89

16.38

u/ml

0.05

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

165

199

4.68

56.92

2.0

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

467

1121

2.37

56.28

3.1

2.9

57.37

57.12

0.16

467

1121

(3038515) Glucose [Moles/volume] in Venous blood

227

359

3.57

56.19

4.0

1.6

7.70

6.12

mmol/l

8.52

220

354

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

546

1409

2.21

55.86

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

179

237

4.26

55.58

2.1

2.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

545

1414

2.20

55.05

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

220

346

3.59

54.89

1.2

108.61

123.73

pmol/l

4.41

220

346

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

806

2432

1.90

54.47

1.4

1.2

3.40

3.28

ug/l

0.25

753

2327

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

12.56

54.46

1.9

1.1

211.95

4.30

ug/min

—

(42529406) Shigella sp [Presence] in Stool by Culture

546

1426

2.18

54.28

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

185

258

4.05

53.98

1.5

1.4

10.42

9.99

umol/l

0.42

174

250

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

192

276

3.93

53.94

1.1

1.07

1.05

ratio

0.68

164

223

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

212

329

3.64

53.87

1.1

291.03

281.41

mg/l

0.75

186

311

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

258

460

3.17

53.59

1.3

1.1

—

(3049717) Cytology report of Urine Cyto stain

358

773

2.63

53.49

2.1

2.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

258

461

3.17

53.41

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

262

475

3.12

53.02

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

247

433

3.23

52.67

1.2

1.1

—

(3003129) Base excess in Capillary blood by calculation

174

236

4.16

52.53

2.4

1.3

0.34

0.69

mmol/l

0.79

166

220

(3023199) Leukocytes [#/volume] in Pleural fluid

109

6.67

52.52

1.6

1.3

1849.88

4997.96

e6/l

2.20

(3017704) Immunofixation for Urine

10.46

52.17

1.7

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

201

308

3.68

51.97

6.9

1.6

7.65

5.73

mmol/l

7.22

178

238

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

711

2088

1.95

51.97

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

194

290

3.78

51.84

1.2

1.1

1.92

1.74

mmol/l

1.65

179

275

(40768443) Skin Pathology biopsy report

724

2148

1.93

51.38

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

7.74

51.28

24.2

14.7

117.27

117.11

ug/l

0.01

(3004451) EKG impression Narrative

12.47

50.70

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

118

115

5.78

50.31

1.4

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

845

2677

1.81

49.03

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

247

460

3.04

47.92

1.3

1.5

—

titre

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

105

6.22

47.80

1.6

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

418

1029

2.31

47.68

1.1

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

228

407

3.16

47.32

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

294

611

2.72

47.22

1.1

1.48

1.38

g/l

3.71

263

570

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3340

14483

1.36

47.18

4.4

2.9

1.49

1.62

ug/l

2.18

3053

13662

(3013005) Retinol [Moles/volume] in Serum or Plasma

145

185

4.42

47.06

2.1

2.06

1.84

umol/l

2.10

134

170

(3017354) Segmented neutrophils/Leukocytes in Blood

151

201

4.23

46.66

3.1

1.9

58.15

53.80

1.53

135

177

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

171

252

3.83

46.60

2.0

2.1

13.32

13.66

0.18

166

252

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

883

2880

1.76

46.49

1.5

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

876

2862

1.75

45.84

2.5

1.6

30.26

25.19

u/ml

0.88

842

2775

(40759836) Histone Ab [Presence] in Serum by Immunoblot

221

396

3.15

45.61

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3771

16743

1.34

45.36

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

8.13

45.28

2.5

1.4

0.61

0.64

mmol/l

2.04

(40768441) Liver Pathology biopsy report

145

192

4.25

45.10

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

7.81

44.59

1.6

1.3

9.05

10.96

mmol/l

0.67

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

147

199

4.16

44.54

1.9

96.30

104.42

1.77

133

177

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

219

399

3.10

44.05

1.2

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

150

209

4.04

43.90

1.0

1.1

1.90

7.64

nmol/l

0.90

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

219

400

3.09

43.87

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

2016

15268

0.70

43.45

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

176

281

3.53

43.10

2.3

2.4

198.54

234.04

e6/l

1.58

137

229

(3044242) Glucose [Moles/volume] in Arterial blood

8.48

42.59

1.8

1.4

8.82

6.32

mmol/l

3.06

(3004616) Nuclear Ab [Presence] in Serum

267

560

2.70

42.21

1.3

—

(3045788) Cell count panel - Pleural fluid

6.60

42.13

1.6

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.50

42.10

1.6

1.3

13280.69

58946.81

e6/l

0.74

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

144

201

4.04

42.07

1.1

—

(3047189) Immunofixation for 24 hour Urine

13.33

42.03

2.4

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

209

381

3.10

42.02

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

209

381

3.10

42.02

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

104

5.52

41.78

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

235

462

2.87

41.70

1.5

1.3

—

(3008898) HLA-B27 [Presence]

962

3326

1.66

40.97

1.1

—

(3042631) Mycobacterium sp identified in Specimen

146

212

3.88

40.61

2.4

3.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2664

11383

1.37

40.50

2.2

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

223

433

2.91

40.43

1.5

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

201

367

3.09

40.32

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

227

448

2.86

40.03

1.5

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

135

187

4.06

39.83

3.3

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

222

437

2.87

39.33

1.5

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

215

416

2.92

39.23

1.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

215

417

2.91

39.07

1.5

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

107

123

4.89

38.97

1.2

38.11

10.67

u/l

1.29

113

(40768806) Pleura Pathology biopsy report

6.60

38.82

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

7.26

38.74

1.7

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

7.26

38.74

1.7

1.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

108

126

4.82

38.73

1.2

105.97

65.80

u/l

1.58

117

(3025468) Yersinia sp identified in Specimen by Organism specific culture

212

415

2.88

37.94

1.5

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

124

167

4.18

37.87

1.1

98.79

92.41

1.03

118

(3044927) Protein electrophoresis panel - Urine

108

129

4.71

37.78

1.3

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

9.51

37.75

3.1

1.5

0.95

0.68

0.60

(3017569) Oxygen content in Arterial blood

8.18

37.67

1.8

1.7

16.55

17.88

1.71

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.50

37.65

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

164

276

3.35

37.31

2.3

518.34

523.67

e6/l

0.04

122

214

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

109

133

4.61

37.27

1.6

1.4

7.93

6.63

u/l

0.37

112

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

59.51

37.14

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

104

5.19

37.14

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2229

9380

1.38

36.89

2.1

1.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

142

219

3.65

36.54

1.2

17.82

6.09

u/ml

0.49

(3023419) Bacteria identified in Sputum by Culture

166

287

3.26

36.29

3.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

100

5.23

36.25

2.2

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

100

5.23

36.25

2.2

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

100

5.23

36.25

2.2

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

100

5.23

36.25

2.2

1.2

—

(3000330) Specific gravity of Urine by Test strip

646

2072

1.77

35.91

2.9

2.1

1.02

ratio

0.16

576

1786

(3020717) Zinc [Moles/volume] in Serum or Plasma

165

287

3.24

35.75

1.7

1.4

22.20

22.64

umol/l

0.06

152

274

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

307

751

2.31

35.60

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

333

845

2.23

35.52

1.5

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

198

390

2.86

35.09

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

106

134

4.45

34.87

1.4

1.2

5.91

5.03

mmol/l

3.78

120

(40757494) Bilirubin.total [Moles/volume] in Blood

6.51

34.65

2.7

3.0

16.90

45.93

umol/l

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

132

201

3.70

34.57

1.3

1.1

70.50

92.94

1.73

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

100

121

4.65

34.54

1.3

1.2

26.60

12.49

u/l

1.28

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

103

130

4.46

33.96

2.4

1.6

93.97

68.09

ng/l

2.09

103

130

(3022621) pH of Urine by Test strip

1321

5135

1.48

33.63

2.3

1.9

6.16

6.23

1.66

787

3006

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

100

125

4.50

33.34

1.3

1.2

82.48

72.54

u/l

0.46

102

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

230

506

2.57

33.30

1.2

1.1

39.00

41.80

mg/l

0.37

197

420

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

200

409

2.76

33.21

1.3

1.2

60.64

32.07

u/ml

0.54

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

616

1998

1.75

32.98

1.2

1.1

4.38

4.20

0.18

108

451

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2292

16389

0.75

32.84

1.9

1.8

3.54

3.48

ratio

1.51

1729

12059

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

181

353

2.89

32.66

1.3

1.2

80.45

68.82

0.84

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

230

512

2.54

32.55

1.1

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

4.78

32.43

1.4

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

937

3412

1.57

32.23

2.0

1.3

4.05

3.44

mg/l

1.11

748

2016

(3034426) Prothrombin time (PT)

5.24

32.07

1.3

1.2

28.48

27.78

0.34

(1761482) Bacteria [#/volume] in Urine by Culture

272

664

2.31

31.73

3.2

2.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

188

382

2.77

31.60

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

113

164

3.88

31.55

1.7

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

143

247

3.26

31.37

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

170

3.81

31.36

1.1

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

12.34

31.32

2.3

1.6

1155.18

1680.00

e6/l

0.16

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

4.72

31.30

1.4

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

186

378

2.77

31.26

1.1

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

105

145

4.07

31.19

2.3

28.14

27.86

umol/l

0.09

133

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

133

220

3.40

31.11

1.7

1.4

1464676.64

368883.13

iu/ml

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

132

218

3.41

30.94

2.0

2.1

133.58

114.56

1.96

126

208

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

154

3.94

30.85

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

220

493

2.52

30.75

1.1

235.40

224.19

mg/l

0.32

198

440

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1744

12863

0.73

30.58

1.6

1.5

3.47

3.56

mmol/l

2.48

1198

8358

(40768800) Prostate Pathology biopsy report

135

229

3.32

30.44

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

49.39

30.14

8.0

1.6

5.32

4.42

kpa

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

211

469

2.54

29.99

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

375

1068

1.99

29.92

1.5

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

8.67

29.85

2.0

3.7

2.14

1.04

mmol/l

0.95

(3006245) CD3-CD19+ cells/cells in Blood

117

184

3.58

29.41

2.2

2.7

10.95

9.26

0.66

110

184

(3022493) Free Hemoglobin [Mass/volume] in Plasma

108

4.53

29.28

10.1

1.2

2318.58

14474.68

mg/l

1.15

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

180

375

2.70

28.96

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

10.10

28.87

1.0

1.1

—

(4024509) Urine culture

647

2213

1.66

28.63

2.0

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

675

2344

1.64

28.18

1.6

28.35

0.53

iu/ml

0.49

117

390

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

10.71

27.83

4.3

4.8

43.71

15.23

ug/min

2.11

(3006270) Folate [Moles/volume] in Blood

140

258

3.05

27.83

1.1

396.20

403.18

nmol/l

0.14

128

249

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

169

349

2.73

27.65

1.3

1.2

35.10

71.13

u/ml

—

(3051611) Lipemic interference index of Serum or Plasma

133

239

3.13

27.52

3.6

1.9

13.44

14.84

index

0.59

116

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

169

350

2.72

27.51

1.2

1.3

104.00

324.29

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

169

350

2.72

27.51

1.2

1.3

194.38

217.40

titre

0.11

(4027681) Cerebrospinal fluid IgG ratio and IgG index

181

390

2.61

27.37

1.2

0.61

0.76

ratio

2.12

107

228

(3004716) Salmonella sp identified in Stool by Organism specific culture

1184

4692

1.44

27.14

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

4.46

26.86

3.3

3.2

27.64

27.35

umol/l

0.06

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.92

26.48

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

136

255

3.00

26.31

1.5

1.8

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

26.23

1.7

0.0

606.28

—

nmol/l

—

(37021550) Renin [Units/volume] in Plasma --upright

8.41

25.86

1.6

1.5

146.16

42.44

mu/l

1.37

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

11.22

25.81

2.0

1.5

3248.68

17855.57

e6/l

—

(3000060) B lymphocytes [#/volume] in Blood

153

3.64

25.54

2.0

2.3

0.20

0.25

e9/l

0.48

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

138

3.79

25.32

1.0

38.63

47.36

ng/l

0.78

105

(3019832) Treponema pallidum Ab [Presence] in Serum

3858

18273

1.24

25.21

1.9

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

139

3.76

25.09

1.0

847.64

709.12

ng/l

1.44

104

(3038026) Centromere Ab [Units/volume] in Serum

147

298

2.78

24.92

1.3

1.2

35.64

18.70

u/ml

0.37

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.69

24.91

1.8

1.3

2742.70

1498.00

u/ml

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

140

3.73

24.86

1.0

285.48

358.86

ng/l

1.25

109

(3026692) Albumin [Mass/volume] in Peritoneal fluid

10.92

24.79

1.6

1.2

12.64

9.68

g/l

0.47

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

4.03

24.78

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

103

168

3.45

24.68

2.5

2.7

53.19

51.32

umol/l

0.22

163

(3000475) Leukocytes [#/volume] in Synovial fluid

334

979

1.93

24.64

1.7

8182.54

10171.29

e6/l

0.68

249

718

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

113

198

3.21

24.37

2.5

3.2

43.72

44.02

0.05

(44806420) Estimation of glomerular filtration rate

282

781

2.04

24.35

2.3

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

759

6226

0.67

24.25

1.1

0.66

0.64

ratio

0.31

540

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

147

3.59

23.90

1.4

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.21

23.84

6.2

1.8

4.83

4.74

kpa

0.16

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.21

23.84

6.2

1.8

11.90

10.60

kpa

1.25

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.12

23.82

2.5

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.12

23.82

2.5

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

8.52

23.76

1.4

1.2

352.87

244.43

pmol/l

1.45

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

145

3.60

23.74

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

301

862

1.97

23.74

1.2

1.1

1.03

1.09

0.05

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

111

196

3.18

23.67

1.1

1.2

0.30

0.29

g/l

1.01

158

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.98

23.56

2.5

1.1

—

(3044007) Cell count panel - Peritoneal fluid

10.90

23.43

1.8

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

9.26

23.21

1.3

1.4

38.88

36.75

ng/l

0.04

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

114

208

3.08

23.11

1.1

1.3

—

(44806071) Cardiolipin IgM antibody measurement

5.61

23.09

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.79

23.00

1.5

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.79

23.00

1.5

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

6.59

22.65

1.3

60.96

68.88

ug/l

0.83

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

154

339

2.56

22.44

1.1

1.05

1.06

u/l

0.12

116

(3033799) Differential panel - Peritoneal fluid

10.59

22.41

2.3

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

159

356

2.51

22.40

1.5

8.78

7.01

ug/l

0.32

147

320

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

160

3.37

22.34

1.1

1.2

2.63

3.55

u/ml

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

123

242

2.86

22.03

1.9

1.2

186.78

181.59

u/l

0.65

123

242

(3035880) pH of Pleural fluid

6.86

21.88

1.2

1.3

7.41

7.32

0.86

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

193

480

2.26

21.75

1.3

0.98

4.16

u/ml

4.89

281

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.11

21.50

1.5

1.1

127.40

122.33

nmol/l

0.09

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

149

330

2.54

21.47

1.5

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13295

71173

1.22

21.43

20.6

6.7

333.10

334.08

g/l

30.22

13241

70623

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

110

3.88

21.43

1.3

1.1

9.80

5.92

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

310

931

1.88

21.35

2.5

2.6

40.96

31.54

iu/ml

0.26

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

163

3.27

21.21

1.2

1.3

—

(44813793) Dust mix specific IgE antibody measurement

195

493

2.23

21.18

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

106

196

3.04

21.08

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.54

20.83

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.40

20.68

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

102

187

3.07

20.57

1.1

1.2

109.11

107.55

0.19

172

(21494814) CD8 cells/Lymphocytes in Specimen

114

3.74

20.49

2.0

2.1

31.03

27.19

1.42

114

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

419

1417

1.67

19.44

1.5

1.4

75.59

47.31

pmol/l

2.85

404

1374

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

33.61

19.42

2.1

1.8

12.41

6.78

pmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

138

310

2.50

19.39

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

182

3.03

19.39

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

144

3.32

19.38

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.01

18.88

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

164

405

2.28

18.85

2.1

1.5

23.12

26.61

mg/l

0.41

152

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1049

4337

1.38

18.79

1.4

1.3

233.78

232.59

miu/ml

0.03

515

2317

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

175

3.02

18.54

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

588

2186

1.52

18.46

2.2

2.4

5.30

5.43

umol/l

0.12

417

1613

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

446

1555

1.62

18.42

1.2

1.1

18.28

12.65

au/ml

0.93

132

587

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.61

18.11

2.0

2.3

1.28

1.23

umol/l

0.25

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

134

3.31

18.01

1.3

25.00

147.69

titre

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

115

3.51

17.89

1.9

1.6

0.18

0.30

nmol/l

1.05

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

151

3.12

17.55

1.1

87.34

97.38

1.63

(3001186) Copper [Moles/volume] in Serum or Plasma

117

3.45

17.47

1.7

1.3

18.03

16.15

umol/l

1.52

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.61

17.27

1.4

1.1

1.19

1.16

mmol/l

1.44

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

156

3.06

17.19

1.2

104.14

117.21

1.54

140

(3014148) Varicella zoster virus Ab [Titer] in Serum

376

1284

1.65

16.87

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

458

1643

1.58

16.86

1.5

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

408

1424

1.62

16.82

1.1

3.21

3.35

eliau/ml

0.07

207

869

(4034850) Laboratory test

450

1609

1.58

16.80

11.2

4.1

—

(3001556) Androgen free Index in Serum or Plasma

110

3.47

16.63

1.5

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

22.42

16.60

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

147

367

2.25

16.55

3.1

1.8

23.07

29.60

mg/l

1.45

111

246

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

16.39

1.2

0.0

47.72

—

nmol/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

103

218

2.65

16.32

3.6

4.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

575

2186

1.49

16.28

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

165

2.93

16.20

1.4

13.40

27.46

u/ml

1.60

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

204

585

1.96

16.19

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

7.24

16.11

3.1

2.3

62.97

40.19

pmol/l

0.53

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

301

981

1.73

16.04

1.7

1.8

5186.67

3727.62

titre

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

10.01

15.99

1.2

1.0

—

mmol/l

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

323

1077

1.69

15.87

1.5

1.4

31.14

36.18

nmol/l

1.85

293

1029

(3010370) Gastrin [Moles/volume] in Serum or Plasma

5.22

15.77

2.6

1.7

45.48

14.07

pmol/l

1.53

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

9.11

15.74

1.0

1.3

61.42

34.38

mg/l

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

147

3.02

15.67

1.2

1.1

86.71

99.77

1.58

(3003329) Lymphocytes/Leukocytes in Synovial fluid

142

358

2.23

15.66

1.7

1.5

39.37

42.69

0.37

243

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.59

15.56

1.4

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.95

15.56

2.2

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

166

450

2.08

15.35

1.1

1.0

1603.78

1377.21

miu/ml

1.60

166

450

(3014271) Vancomycin [Susceptibility]

4.64

15.05

2.3

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

113

3.28

14.91

1.5

1.7

9.64

8.35

ug/l

1.28

113

(3033923) Metanephrine [Moles/time] in 24 hour Urine

7.47

14.89

1.1

0.71

0.86

umol/24h

0.52

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.07

14.81

1.9

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

14.75

2.6

0.0

242.71

—

ug/l

—

(4281824) Cell count and differential, peritoneal fluid

133

337

2.22

14.54

1.2

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.57

14.49

1.8

1.3

22.60

20.32

g/l

0.15

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2521

12011

1.21

14.48

3.8

2.7

22.81

22.52

0.34

940

4084

(3045683) HLA typing for celiac disease panel - Blood or Tissue

182

527

1.94

14.13

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

362

1287

1.59

13.92

1.2

—

(3028433) Virus identified in Specimen by Culture

104

3.29

13.90

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.49

13.88

2.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.51

13.72

1.1

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

7.78

13.69

1.4

1.2

28.31

117.00

ug/l

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

144

2.88

13.69

1.1

5.33

3.06

iu/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.54

13.49

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

3.20

13.33

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.43

13.31

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

850

3590

1.34

13.31

1.4

—

(3044941) Cell count panel - Synovial fluid

225

713

1.78

13.28

1.5

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

+∞

13.11

6.6

0.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

3.82

12.63

1.0

77.09

77.34

ug/l

0.01

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.51

12.51

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.45

12.46

1.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

12.29

1.3

0.0

120.25

—

nmol/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.67

12.24

2.9

1.2

6.56

5.52

mmol/l

0.64

(3009871) Measles virus Ab [Titer] in Serum

106

264

2.25

12.14

1.8

1.7

3820.00

2898.29

titre

0.39

(3020491) Glucose [Moles/volume] in Blood

145

411

1.98

12.02

1.8

1.3

6.40

5.23

mmol/l

4.04

105

335

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.51

11.82

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.47

11.61

1.1

—

(3048879) Bone marrow aspiration report

7.84

11.57

2.4

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

18.66

11.43

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

837

3611

1.31

11.35

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

21.28

11.28

3.0

3.4

2.44

1.73

mu/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

241

818

1.66

11.24

1.6

1.2

229.13

2494.44

pmol/l

1.03

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

321

1169

1.55

11.23

1.1

2.69

3.00

0.30

266

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

6.44

10.97

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

16.01

10.91

1.8

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

165

510

1.82

10.66

1.8

1.6

49.59

46.87

0.33

103

362

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

+∞

10.65

4.4

0.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.77

10.27

1.1

1.3

1.89

1.74

iu/ml

0.20

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.39

10.24

1.8

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

15.21

10.22

3.3

1.0

328.21

224.57

umol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

218

2.24

9.91

1.2

1.3

—

(3036180) Methadone [Presence] in Urine

+∞

9.83

3.0

0.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

347

1326

1.47

9.75

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

164

2.43

9.67

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

2.67

9.65

3.0

2.6

1.58

2.16

ratio

2.26

108

(3001964) Herpes simplex virus Ag [Presence] in Specimen

108

2.80

9.65

1.5

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

4.14

9.65

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

11.82

9.34

2.6

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

182

2.31

9.22

1.0

1.1

138.81

243.35

ng/l

0.34

(3007463) Buprenorphine [Presence] in Urine

17.93

9.14

4.9

4.0

—

(3024869) Neuronal Ab [Presence] in Serum

4.17

9.12

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.60

9.09

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.55

9.03

1.0

—

(3019174) dRVVT (LA screen)

4.00

9.00

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.93

8.89

1.1

72.25

101.85

1.13

(3042010) Triglyceride [Moles/volume] in Pleural fluid

6.72

8.88

1.2

1.3

2.41

0.51

mmol/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

196

2.23

8.88

1.3

1.1

315.49

384.49

u/l

0.17

187

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

219

2.15

8.77

1.6

1.5

2.06

3.18

u/field

0.51

157

(3033099) Centromere Ab [Titer] in Serum

108

2.70

8.73

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

106

304

1.96

8.65

1.1

5.92

14.03

u/ml

2.02

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

382

1523

1.41

8.64

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

289

1.98

8.61

1.8

1.6

2.05

1.99

u/field

0.03

156

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

2.75

8.50

1.0

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

3.87

8.36

3.1

1.3

3.29

3.83

0.16

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.38

8.33

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.49

8.32

1.5

1.3

—

(3017509) Phencyclidine [Presence] in Urine

2.83

8.25

1.9

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

8.10

1.1

62.87

95.00

1.15

(4015189) Microbial culture of sputum

3.65

8.06

2.2

1.5

—

(3002619) Bacteria identified in Specimen by Culture

100

2.69

8.05

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

3.14

8.03

2.4

1.2

40.78

41.18

g/l

0.15

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

14.00

7.96

6.7

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

2.80

7.93

1.3

41.31

53.20

1.03

(3024263) Appearance of Synovial fluid

175

2.21

7.75

2.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.32

7.72

1.4

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.30

7.72

1.8

1.6

1.82

1.87

mg/l

0.02

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

9.52

7.67

2.9

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.71

7.67

4.5

4.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.20

7.66

1.1

1.6

1.31

1.78

ug/l

0.96

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

100

2.63

7.60

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.87

7.55

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

12.00

7.52

4.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

108

2.54

7.42

1.3

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

4.07

7.39

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.07

7.39

2.7

2.2

7.92

4.79

ug/l

0.54

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

0.98

3.66

mg/l

2.11

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

0.47

1.29

mg/l

1.00

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

4.48

1.86

mg/l

0.88

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

1.31

4.18

mg/l

2.52

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

0.56

1.31

mg/l

1.14

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

1.93

4.36

mg/l

1.04

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

1.45

1.96

mg/l

0.22

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

2.77

5.90

mg/l

1.31

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.26

7.36

1.8

1.6

1.81

1.79

mg/l

0.01

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.31

7.30

1.2

1.4

1.25

2.62

mmol/l

2.15

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

144

2.30

7.25

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

106

2.54

7.25

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.68

7.19

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.68

7.19

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.68

7.19

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.68

7.19

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

623

2754

1.28

7.15

1.2

1.1

2.40

2.59

u/ml

0.16

321

1455

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.52

6.93

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

117

375

1.75

6.89

1.4

1.5

113851.27

79545.32

e6/l

0.21

233

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

186

677

1.54

6.72

1.1

7.23

6.03

iu/ml

0.28

221

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

463

1.66

6.70

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

187

2.07

6.65

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

188

2.06

6.57

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

188

2.06

6.57

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

+∞

6.56

1.0

0.0

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

+∞

6.56

2.3

0.0

221.50

—

nmol/l

—

(40760409) HLA-A [Type] by High resolution

+∞

6.56

1.0

0.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

5.01

6.54

1.6

1.1

1.36

6.51

ml/s/173m2

0.53

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

9.80

6.50

1.4

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

460

0.41

6.42

6.6

7.1

11.18

8.35

1.29

460

(40761995) Spermatozoa Progressive [#/volume] in Semen

460

0.41

6.42

3.3

3.6

43.29

46.54

0.46

460

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.39

6.36

1.0

0.02

0.04

u/ml

0.70

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.39

6.36

1.0

—

(3025130) Human papilloma virus identified in Specimen

433

1858

1.31

6.28

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

533

2356

1.27

6.17

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

532

2356

1.27

6.08

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

291

1182

1.38

6.05

3.8

2.3

23.14

26.43

mg/l

0.98

198

753

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

11.20

5.96

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.20

5.78

1.0

21.56

6.08

u/l

0.52

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.74

1.3

0.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

5.74

4.7

0.0

519.86

—

umol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

12.31

5.70

4.8

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

188

713

1.48

5.69

1.5

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

177

664

1.50

5.65

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.97

5.63

2.8

2.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

320

1337

1.35

5.61

1.4

1.5

7.08

6.15

mmol/l

6.45

294

1200

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

3.56

5.53

1.1

40.36

80.13

2.08

(3032057) Clostridioides difficile [Presence] in Stool

3.56

5.53

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.56

5.53

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.67

5.40

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

134

2.13

5.39

2.8

1.3

111.72

103.76

ng/l

0.13

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.26

5.31

3.5

5.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

106

2.27

5.27

1.0

0.01

0.02

u/ml

1.21

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.97

5.27

1.2

1.3

0.69

0.57

iu/ml

0.19

(3034891) Synovial lining cells/cells in Synovial fluid

198

1.90

5.20

1.8

1.4

5.92

5.26

0.09

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

148

2.05

5.15

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.42

5.11

4.5

3.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.47

4.95

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.50

4.95

2.1

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

4.92

1.0

0.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

4.92

1.0

0.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.60

4.79

1.1

1.52

1.29

umol/24h

0.49

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.49

4.78

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.29

4.76

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.52

4.73

1.3

1.1

0.72

104.69

mg/l

0.76

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.86

4.60

1.3

1.9

17.60

13.09

nmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3124

16227

1.10

4.56

1.6

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1884

9538

1.12

4.55

2.8

2.3

0.62

0.69

ug/l

3.04

1061

4080

(3003888) Timothy IgE Ab [Units/volume] in Serum

529

2436

1.22

4.39

1.1

5.71

6.31

u/ml

0.33

293

1402

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

191

767

1.40

4.38

1.4

1.3

303.08

199.57

pmol/l

0.35

191

767

(3028679) Herpes simplex virus Ab [Presence] in Serum

147

566

1.46

4.24

1.2

—

(3013466) aPTT in Blood by Coagulation assay

3.25

4.22

1.1

36.34

37.86

0.26

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.60

4.18

1.3

1.0

—

(3020650) Glucose [Presence] in Urine

273

1.66

4.17

1.5

1.4

0.07

0.00

estimate

0.80

273

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.28

4.15

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

205

845

1.36

4.05

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

225

1.72

4.01

1.1

1.22

5.53

u/ml

0.63

204

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.17

3.96

1.5

1.0

—

(3025577) Chromium [Mass/volume] in Blood

140

1.92

3.96

2.2

2.3

2.95

2.81

ug/l

0.06

119

(3020393) Adenovirus Ag [Presence] in Stool

2.55

3.94

1.6

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

103

375

1.54

3.91

1.8

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.05

3.87

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.05

3.87

1.3

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.05

3.87

1.1

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

503

2341

1.21

3.80

1.1

0.95

1.11

u/ml

0.26

220

1096

(3050794) Legionella sp Ab [Presence] in Serum

3.36

3.70

1.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

222

1617

0.77

3.65

1.6

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.67

3.64

1.7

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

115

438

1.47

3.57

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

514

2415

1.20

3.54

1.1

1.77

2.35

u/ml

0.62

250

1207

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.88

3.54

2.3

2.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

134

1.88

3.53

2.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.17

3.53

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

109

412

1.48

3.52

1.0

9.89

12.83

u/ml

0.63

288

(3026470) Cobalt [Mass/volume] in Blood

147

1.83

3.47

2.2

2.3

3.23

3.01

ug/l

0.10

135

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.20

3.39

1.2

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

2.88

3.36

1.5

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.83

3.35

1.0

0.03

0.47

u/ml

0.47

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.09

3.35

3.5

3.0

47.30

44.73

umol/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.60

3.33

1.8

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.80

3.21

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

135

1.83

3.19

1.4

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.31

3.16

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.67

3.15

1.4

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

148

1.78

3.15

1.0

5.26

4.64

u/ml

0.17

148

(40765089) Chromosome analysis panel - Blood by G-banded

143

584

1.37

3.09

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.17

3.01

1.7

1.5

0.48

0.35

ug/l

0.67

(3033942) Copper [Moles/time] in 24 hour Urine

3.16

2.97

1.6

1.0

2.10

0.28

umol/24h

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.43

2.95

1.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.60

2.94

1.1

—

(3022475) Manganese [Moles/volume] in Blood

3.85

2.93

1.5

1.4

0.15

umol/l

0.03

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.54

2.91

1.0

0.00

0.04

u/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

121

486

1.40

2.91

1.1

9.37

7.63

mm/h

1.16

121

486

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.20

2.88

1.1

1.5

27.87

45.18

mg/l

1.18

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

131

536

1.37

2.83

1.4

1.5

5.38

4.95

mmol/l

4.02

119

516

(3006462) Nitrate [Presence] in Urine

258

1.54

2.82

2.3

1.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.03

2.80

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

184

794

1.30

2.80

1.1

18.80

20.75

u/ml

0.34

351

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.20

2.79

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.62

2.77

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.93

2.76

1.6

1.2

37.64

42.81

g/l

1.07

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

135

1.74

2.68

1.0

1.1

0.06

0.85

u/ml

0.80

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.80

2.67

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.20

2.66

1.7

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

567

3636

0.87

2.65

1.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

136

1.73

2.62

1.0

1.1

0.03

1.02

u/ml

0.91

(3014133) Dog dander IgE Ab [Units/volume] in Serum

449

2148

1.17

2.62

1.1

3.27

4.60

u/ml

1.14

223

1108

(4211845) Urine protein measurement

287

1.48

2.57

2.2

1.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.72

2.55

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.44

2.55

1.1

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

148

630

1.32

2.52

1.6

1.4

0.51

0.52

e9/l

0.27

148

630

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

138

583

1.33

2.48

1.9

3.60

2.78

u/ml

0.19

195

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

332

1.44

2.44

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.55

2.44

1.0

1.3

—

(40757373) Influenza virus identified in Isolate

2.38

2.43

1.5

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.90

2.42

4.7

3.7

4.34

4.25

mmol/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.94

2.40

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.29

2.39

1.7

2.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.08

2.37

1.0

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.05

2.28

1.0

1.2

11.60

26.80

u/ml

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.87

2.26

1.0

0.37

1.46

u/ml

0.40

(3023430) Cat dander IgE Ab [Units/volume] in Serum

419

2024

1.16

2.22

1.1

5.47

5.18

u/ml

0.07

177

946

(3001729) Color of Synovial fluid

3.11

2.22

1.4

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.27

2.22

1.4

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.36

2.20

1.0

1.1

279.78

243.60

u/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.69

2.16

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

188

845

1.25

2.15

1.1

0.61

4.88

u/ml

1.35

261

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.03

2.13

2.1

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.80

2.10

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.80

2.10

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.80

2.10

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.80

2.10

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.80

2.10

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.80

2.10

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

3.15

2.07

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.45

2.05

1.3

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.99

2.04

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.75

2.01

11.0

2.6

0.19

0.18

0.15

(40758292) HTLV I+II Ab panel - Serum

109

1.70

1.99

1.5

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

244

1.45

1.96

1.1

1.2

1.27

14.11

u/ml

2.00

165

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

123

1.64

1.93

1.1

1.0

0.02

0.28

u/ml

1.54

(3049233) Organic acids panel - Urine

3.56

1.90

1.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.49

1.90

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.13

1.85

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

183

841

1.22

1.77

1.0

1.1

3.33

8.33

u/ml

0.47

206

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

3.73

1.75

1.2

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.73

1.75

1.2

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.73

1.75

1.0

3.00

2.78

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.27

1.74

1.2

1.3

7.22

6.20

mmol/l

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.67

1.71

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.18

1.71

1.1

—

(3005033) Fetal Nuchal fold Thickness US

815

4973

0.91

1.71

1.5

1.24

1.25

0.26

610

3764

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

367

1799

1.14

1.68

1.1

0.47

0.42

u/ml

0.05

486

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.32

1.67

1.0

0.00

0.14

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

133

1.56

1.66

1.1

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

129

1.56

1.64

1.1

1.0

0.19

0.58

u/ml

0.83

(3015076) Soybean IgE Ab [Units/volume] in Serum

174

807

1.21

1.57

1.0

1.1

0.31

1.12

u/ml

1.10

179

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.66

1.57

1.0

1.1

0.67

17.15

u/ml

0.49

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

109

1.59

1.54

1.5

1.4

41.94

44.35

0.13

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.64

1.52

1.1

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

2.28

1.49

1.2

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

249

1.37

1.49

1.1

29.85

24.98

iu/ml

0.38

249

(3047352) Trisomy 18 risk [Likelihood] in Fetus

841

5084

0.92

1.46

1.5

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.50

1.45

1.2

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.83

1.45

1.3

1.8

0.56

0.80

u/field

0.50

(3012494) Peanut IgE Ab [Units/volume] in Serum

294

1.33

1.44

1.1

4.26

22.53

u/ml

0.94

204

(3036071) Salmonella sp Ab [Titer] in Serum

262

1.35

1.39

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

856

5155

0.93

1.37

1.5

1.6

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.70

1.36

4.1

1.6

16.08

3.02

—

(3051101) Glucose [Moles/volume] in Cord blood

2.49

1.32

5.9

1.3

9.20

6.13

mmol/l

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

3.11

1.31

1.2

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.11

1.31

2.8

1.9

29.52

27.37

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.36

1.27

1.1

20.94

22.82

mg/24h

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.64

1.27

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.58

1.25

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

2.24

1.21

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.87

1.21

2.4

2.8

3.56

6.13

ug/l

—

(3032641) Amino acids panel - Urine

2.80

1.19

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.80

1.19

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

150

1.42

1.17

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.57

1.14

1.0

0.18

3.96

u/ml

1.29

(3016031) Almond IgE Ab [Units/volume] in Serum

1.54

1.14

1.0

0.17

1.42

u/ml

1.75

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.02

1.05

1.1

1.0

—

2.52

u/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.74

1.01

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.78

0.99

1.0

1.43

0.88

u/ml

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.47

0.99

1.1

4.70

9.28

u/ml

1.12

(3011841) English Walnut IgE Ab [Units/volume] in Serum

137

1.39

0.98

1.1

0.02

5.73

u/ml

1.94

109

(3005011) Chlamydia sp Ab [Titer] in Serum

105

1.44

0.94

1.7

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.95

0.90

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

135

1.37

0.89

1.1

0.07

4.56

u/ml

2.70

102

(3029396) Erythrocyte agglutination [Presence] in Blood

128

617

1.16

0.87

2.8

3.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

858

4550

1.06

0.84

1.6

1.5

58.98

60.83

ug/l

0.52

858

4550

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.45

0.84

1.1

3.49

0.21

u/ml

0.45

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.83

0.0

1.1

—

22.36

—

(3016135) IgD [Mass/volume] in Serum

2.33

0.79

1.2

1.0

24.38

53.43

mg/l

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.15

0.75

1.0

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

117

0.67

0.72

1.0

10.42

8.79

mu/l

—

101

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

131

1.32

0.72

1.4

1.5

5.66

5.28

mmol/l

2.18

131

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.60

0.68

1.0

0.61

0.31

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2176

11858

1.03

0.64

1.6

959.53

1029.22

mu/l

1.85

1870

10319

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

280

1696

0.92

0.64

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.75

0.63

1.0

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

114

564

1.13

0.60

1.3

1.4

1130.00

984.55

titre

—

110

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.34

0.57

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1032

5989

0.96

0.56

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

347

1.16

0.56

6.9

7.4

1177.81

1740.56

u/ml

0.13

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

642

1.12

0.56

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1066

5760

1.04

0.55

1.6

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.30

0.45

6.2

3.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1058

6104

0.97

0.45

1.5

0.94

ratio

0.07

648

3735

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1058

6104

0.97

0.45

1.5

1.18

1.17

ratio

0.09

653

3766

(3033086) Enterovirus Ab [Titer] in Serum

1.65

0.44

1.2

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.65

0.44

1.4

1.2

773.00

488.06

mg/24h

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

455

0.89

0.43

3.5

3.9

7.81

9.47

mg/l

1.29

372

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1057

6092

0.97

0.43

1.5

1.12

1.17

ratio

1.15

647

3724

(3022670) pH of Venous cord blood

1.47

0.43

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.31

0.43

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

1.55

0.42

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

239

0.84

0.42

1.9

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1121

6440

0.97

0.39

1.5

1.6

60.32

63.49

ug/l

1.36

956

5478

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.46

0.36

1.0

0.72

3.43

u/ml

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

215

1.15

0.33

1.0

1.1

1.17

1.20

mom

0.11

215

(4133840) Spirometry

265

1.12

0.30

1.2

1.1

—

(3006598) pH of Arterial cord blood

104

0.81

0.29

1.2

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

134

0.84

0.28

1.4

1.1

6.80

5.54

mmol/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

389

1.08

0.23

2.1

2.2

9.16

10.34

mg/l

1.00

322

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.26

0.21

1.3

1.2

334.91

304.76

umol/24h

0.15

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

310

1695

1.02

0.14

1.6

7.63

7.34

mmol/l

1.75

303

1623

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

371

2034

1.02

0.13

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

122

1.10

0.12

2.2

2.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

397

0.96

0.10

2.9

3.1

98.31

117.44

au/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

525

1.03

0.09

1.2

65.19

69.82

ug/l

0.48

525

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.14

0.09

1.1

61.33

96.00

titre

2.44

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.12

0.09

1.2

1.1

232.50

289.42

u/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.80

0.08

1.2

1.1

0.00

1.41

u/ml

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.86

0.07

1.6

1.3

1.59

1.70

mg/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

297

1.04

0.06

1.7

1.8

51.40

120.88

au/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1383

7708

1.00

0.05

1.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

133

1.05

0.04

1.1

1.0

0.08

1.83

u/ml

1.45

101

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.93

0.04

1.4

1.7

—

(4038314) Semen analysis, post vasectomy

123

0.96

0.03

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.98

0.00

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.95

0.00

7.6

5.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.98

-0.00

1.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.97

-0.00

1.1

8.88

8.34

mmol/l

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HYPOTHYROIDISM – Hypothyroidism (congenital or acquired)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hypothyroidism (congenital or acquired)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints